mp:Vdraft Sandbox: verschil tussen versies

Uit informatiestandaarden
Naar navigatie springen Naar zoeken springen
 
(195 tussenliggende versies door 2 gebruikers niet weergegeven)
Regel 1: Regel 1:
 +
{{anchor|tabel1}}
 +
{| class="wikitable" "cellpadding="10"
 +
|+Tabel 1. Overzicht situaties specifieke en generieke MBH-id voor EVS en AIS
 +
|-
 +
! style="text-align:left;"|Situatie
 +
! style="text-align:left;"|EVS
 +
! style="text-align:left;"|AIS
 +
! style="text-align:left;"|ETDR
 +
|-
 +
! style="text-align:left;"|Migreren van actuele en recent gestopte medicatie
 +
| style="background-color: white;vertical-align:top;"|Specifieke MBH-id||Generieke MBH-id
 +
| style="background-color: white;vertical-align:top;"|Generieke MBH-id
 +
|-
 +
! style="text-align:left;"|Migreren van historische medicatie
 +
| style="background-color: white;vertical-align:top;"|Generieke MBH-id||Generieke MBH-id
 +
| style="background-color: white;vertical-align:top;"|Generieke MBH-id
 +
|-
 +
! style="text-align:left;"|Starten van nieuwe MBH
 +
| style="background-color: white;vertical-align:top;"|Specieke MBH-id||Generieke MBH-id<ref>AIS initieert in principe géén specifieke MBH-id. Alleen wanneer er geen PRK is, maakt het AIS een specifieke MBH-id aan (zie paragraaf [[#Bijzondere situaties|Bijzondere situaties]]).</ref>
 +
| style="background-color: white;vertical-align:top;"|Generieke MBH-id
  
__NUMBEREDHEADINGS__
+
|-
{{DISPLAYTITLE:Beschikbaarstellen medicatiegegevens 9 2.0 - MA: addendum inhoudelijke gegevens kwalificatie}}
 
 
 
=Addenda voor inhoudelijke gegevens=
 
== Overzicht van scenario's voor sturend/beschikbaarstellend systeem ==
 
 
 
=== Scenarioset 0===
 
<section begin=overview-MGB-0 />
 
{| class="wikitable"
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
| Scenario|| Screenshots?|| Beschrijving
 
|-style="vertical-align:top;|style="background-color: white;"
 
|0.1|| || Alle medicatieafspraken van de patiënt, zonder aanvullende filter criteria<br/>(Antwoord: bericht met 6 medicatieafspraken)
 
|-style="vertical-align:top;|style="background-color: white;"
 
|0.2|| || Specifieke medicatieafspraak met identificaties als filter (in kwalificatiesimulator het id van "MBH_920_QA1_MA" invoeren)<br/>(Antwoord: bericht met 1 medicatieafspraak)
 
|-style="vertical-align:top;|style="background-color: white;"
 
|0.3 optioneel|| || Medicatieafspraken met een filter op product code (PRK 3956)<br/>(Antwoord: bericht met 1 medicatieafspraak)
 
|-style="vertical-align:top;|style="background-color: white;"
 
|0.4|| || Medicatieafspraken met een filter op gebruiksperiode – ingangsdatum (alles vanaf T-21)<br/>(Antwoord: bericht met 4 medicatieafspraken)
 
|-style="vertical-align:top;|style="background-color: white;"
 
|0.5|| || Medicatieafspraken met een filter op gebruiksperiode – einddatum (alles voor T-22)<br/>(Antwoord: bericht met 3 medicatieafspraken)
 
|-style="vertical-align:top;|style="background-color: white;"
 
|0.6|| || Medicatieafspraken met een filter op gebruiksperiode – ingangsdatum én einddatum (alles vanaf T-21 tot en met T-7)<br/>(Antwoord: bericht met 3 medicatieafspraken)
 
|-style="vertical-align:top;|style="background-color: white;"
 
|0.7|| || Medicatieafspraken met een specifieke medicamenteuze behandeling als filter (in kwalificatiesimulator het id van "MBH_920_QA1" invoeren)<br/>(Antwoord: bericht met 1 medicatieafspraak)
 
|-style="vertical-align:top;|style="background-color: white;"
 
|0.8|| || Een antwoord zonder medicatieafspraken (filter op gebruiksperiode – einddatum (alles voor T-110))<br/>(Antwoord: bericht zonder medicatieafspraken)
 
|}
 
<section end=overview-MGB-0 />
 
=== Scenarioset 1===
 
<section begin=overview-MGB-1 />
 
{| class="wikitable"
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| MA id
 
|-style="vertical-align:top;|style="background-color: white;"
 
|1.1*|| Maak screenshot(s) waarop zichtbaar is dat de gebruiksperiode ingevoerd kan worden (ingangsdatum/ einddatum).|| Medicatieafspraak gebruiksperiode ingangsdatum en einddatum|| MBH_920_start_eind-BSC|| MBH_920_start_eind_MA-BSC
 
|-style="vertical-align:top;|style="background-color: white;"
 
|1.2a*|| Maak screenshot(s) waarop zichtbaar is dat de gebruiksperiode ingevoerd kan worden (ingangsdatum/ duur).|| Medicatieafspraak gebruiksperiode ingangsdatum en duur (weken)|| MBH_920_start_duur-BSC|| MBH_920_start_duur_MA-BSC
 
|-style="vertical-align:top;|style="background-color: white;"
 
|1.2b*|| Maak screenshot(s) waarop zichtbaar is dat de gebruiksperiode ingevoerd kan worden (ingangsdatum/ duur).|| Medicatieafspraak gebruiksperiode ingangsdatum en duur (dagen)|| MBH_920_start_duur2-BSC|| MBH_920_start_duur2_MA-BSC
 
|-style="vertical-align:top;|style="background-color: white;"
 
|1.3|| || Medicatieafspraak gebruiksperiode ingangsdatum (chronische medicatie)|| MBH_920_chronisch-BSC|| MBH_920_chronisch_MA-BSC
 
|-style="vertical-align:top;|style="background-color: white;"
 
|1.4|| || Medicatieafspraak met eenheid 'dosis/stuks'|| MBH_920_dosis_stuks-BSC|| MBH_920_dosis_stuks_MA-BSC
 
|}
 
<section end=overview-MGB-1 />
 
=== Scenarioset 2===
 
<section begin=overview-MGB-2 />
 
{| class="wikitable"
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| MA id
 
|-style="vertical-align:top;|style="background-color: white;"
 
|2.1|| Maak screenshot(s) waaruit blijkt dat een 'aanvullende instructie' ingevoerd kan worden (als vrije tekst en/of uit keuze lijstje)|| Aanvullende instructie|| MBH_920_aanvullendeinstructie-VNK|| MBH_920_aanvullendeinstructie_MA-VNK
 
|-style="vertical-align:top;|style="background-color: white;"
 
|2.2|| Maak screenshot(s) waaruit blijkt dat een 'toelichting' ingevoerd kan worden|| Toelichting|| MBH_920_toelichting-VNK|| MBH_920_toelichting_MA-VNK
 
|-style="vertical-align:top;|style="background-color: white;"
 
|2.3|| Maak screenshot(s) van de melding/waarschuwing indien de reden van voorschrijven niet wordt ingevuld.|| Reden van voorschrijven|| MBH_920_redenvanvoorschrijven-VNK|| MBH_920_redenvanvoorschrijven_MA-VNK
 
|-style="vertical-align:top;|style="background-color: white;"
 
|2.4|| Maak screenshot(s) waarop de lijst met concepten voor 'aanvullende informatie'  zichtbaar is|| Aanvullende informatie|| MBH_920_aanvullendeinformatiewensen-VNK|| MBH_920_aanvullendeinformatiewensen_MA-VNK
 
|-style="vertical-align:top;|style="background-color: white;"
 
|2.5|| || Toedieningsweg|| MBH_920_Toedieningsweg-VNK|| MBH_920_Toedieningsweg_MA-VNK
 
|}
 
<section end=overview-MGB-2 />
 
=== Scenarioset 3===
 
<section begin=overview-MGB-3 />
 
{| class="wikitable"
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| MA id
 
|-style="vertical-align:top;|style="background-color: white;"
 
|3.1|| || Stop-medicatieafspraak, met reden staken<br/>LET OP: stop medicatieafspraak van scenario 2.1|| MBH_920_aanvullendeinstructie-VNK|| MBH_920_aanvullendeinstructie_MA_staken-VNK
 
|-style="vertical-align:top;|style="background-color: white;"
 
|3.2|| Maak screenshot(s) waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt|| Wijziging medicatieafspraak, met reden wijziging (stop-ma + nieuwe ma)<br/>LET OP: wijziging medicatieafspraak van scenario 2.2|| MBH_920_toelichting-VNK|| MBH_920_toelichting_MA_wijzigingmetVV-VNK<br/>MBH_920_toelichting_MA_techstaken-VNK
 
|-style="vertical-align:top;|style="background-color: white;"
 
|3.3|| Maak screenshot(s) waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt|| Wijziging medicatieafspraak, met reden wijziging (stop-ma + nieuwe ma)<br/>LET OP: wijziging medicatieafspraak van scenario 2.3|| MBH_920_redenvanvoorschrijven-VNK|| MBH_920_redenvanvoorschrijven_MA_wijzigingzonderVV-VNK<br/>MBH_920_redenvanvoorschrijven_MA_techstaken-VNK
 
|-style="vertical-align:top;|style="background-color: white;"
 
|3.4 optioneel|| Maak screenshot(s) waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt|| Onderbreken medicatieafspraak<br/>LET OP: onderbreking medicatieafspraak van scenario 2.4|| MBH_920_aanvullendeinformatiewensen-VNK|| MBH_920_aanvullendeinformatiewensen_MA_onderbreken-VNK
 
|}
 
<section end=overview-MGB-3 />
 
=== Scenarioset 4===
 
<section begin=overview-MGB-4 />
 
{| class="wikitable"
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| MA id
 
|-style="vertical-align:top;|style="background-color: white;"
 
|4.1|| Maak screenshot(s) waarin zichtbaar is dat er een lengte en gewicht ingevoerd kunnen worden|| Medicatieafspraak met lengte en gewicht|| MBH_920_Lengte_Gewicht-MLN|| MBH_920_Lengte_Gewicht_MA_1-MLN
 
|}
 
<section end=overview-MGB-4 />
 
=== Scenarioset 6===
 
<section begin=overview-MGB-6 />
 
{| class="wikitable"
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| MA id
 
|-style="vertical-align:top;|style="background-color: white;"
 
|6.1 optioneel|| || Variabele frequentie|| MBH_920_variabelefrequentie-MSZ|| MBH_920_variabelefrequentie_MA-MSZ
 
|-style="vertical-align:top;|style="background-color: white;"
 
|6.2 optioneel|| || Interval|| MBH_920_interval-MSZ|| MBH_920_interval_MA-MSZ
 
|-style="vertical-align:top;|style="background-color: white;"
 
|6.3 optioneel|| || Variabele hoeveelheid (1)|| MBH_920_variabelehoeveelheid-MSZ|| MBH_920_variabelehoeveelheid_MA-MSZ
 
|-style="vertical-align:top;|style="background-color: white;"
 
|6.4 optioneel|| || Zonder keerdosis|| MBH_920_zonderkeerdosis-MSZ|| MBH_920_zonderkeerdosis_MA-MSZ
 
|-style="vertical-align:top;|style="background-color: white;"
 
|6.5 optioneel|| || Bijzondere keerdosis|| MBH_920_bijzonderekeerdosis-MSZ|| MBH_920_bijzonderekeerdosis_MA-MSZ
 
|-style="vertical-align:top;|style="background-color: white;"
 
|6.6 optioneel|| || Variabele hoeveelheid (2)|| MBH_920_variabelehoeveelheid2-MSZ|| MBH_920_variabelehoeveelheid2_MA-MSZ
 
|-style="vertical-align:top;|style="background-color: white;"
 
|6.7*|| Maak screenshot(s) waarop zichtbaar is dat tijdstip gekozen kan worden|| Tijdstippen|| MBH_920_tijdstippen-MSZ|| MBH_920_tijdstippen_MA-MSZ
 
|-style="vertical-align:top;|style="background-color: white;"
 
|6.8 optioneel|| Maak screenshot(s) waarop zichtbaar is dat weekdagen gekozen kunnen worden|| Weekdagen|| MBH_920_weekdagen-MSZ|| MBH_920_weekdagen_MA-MSZ
 
|-style="vertical-align:top;|style="background-color: white;"
 
|6.9*|| Maak screenshot(s) waarop zichtbaar is dat dagdelen gekozen kunnen worden|| Dagdeel|| MBH_920_dagdeel-MSZ|| MBH_920_dagdeel_MA-MSZ
 
|-style="vertical-align:top;|style="background-color: white;"
 
|6.10 optioneel|| Maak screenshot(s) waarop zichtbaar is dat een cyclisch schema ingevuld kan worden|| Cyclisch schema|| MBH_920_cyclischschema-MSZ|| MBH_920_cyclischschema_MA-MSZ
 
|-style="vertical-align:top;|style="background-color: white;"
 
|6.11 optioneel|| Maak screenshot(s) waarop zichtbaar is dat een doseerschema (met doseerduur) ingevoerd kan worden|| Afbouw schema en doseerduur|| MBH_920_afbouwschema-MSZ|| MBH_920_afbouwschema_MA-MSZ
 
|-style="vertical-align:top;|style="background-color: white;"
 
|6.12 optioneel|| || Variabele hoeveelheid en maximum|| MBH_920_variabelehoeveelheidenmaximum-MSZ|| MBH_920_variabelehoeveelheidenmaximum_MA-MSZ
 
|-style="vertical-align:top;|style="background-color: white;"
 
|6.13 optioneel|| || Toedieningssnelheid|| MBH_920_toedieningssnelheid-MSZ|| MBH_920_toedieningssnelheid_MA-MSZ
 
|-style="vertical-align:top;|style="background-color: white;"
 
|6.14 optioneel|| || Toedieningsduur|| MBH_920_toedieningsduur-MSZ|| MBH_920_toedieningsduur_MA-MSZ
 
|-style="vertical-align:top;|style="background-color: white;"
 
|6.15|| Maak screenshot(s) waarop de lijst met concepten voor 'zo nodig' zichtbaar zijn (incl. eventueel overige concepten of eigen invoer mogelijkheid)|| Zo nodig|| MBH_920_zonodig-MSZ|| MBH_920_zonodig_MA-MSZ
 
|}
 
<section end=overview-MGB-6 />
 
=== Scenarioset 7===
 
<section begin=overview-MGB-7 />
 
{| class="wikitable"
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| MA id
 
|-style="vertical-align:top;|style="background-color: white;"
 
|7.1 optioneel|| Maak screenshot(s) waarop zichtbaar is dat er ingrediënten ingevoerd/gekozen kunnen worden|| Alle ingrediënten|| MBH_920_magistraalalleingredienten-TST|| MBH_920_magistraalalleingredienten_MA-TST
 
|-style="vertical-align:top;|style="background-color: white;"
 
|7.2 optioneel|| Maak screenshot(s) waarop zichtbaar is dat er een ingrediënt ingevoerd/gekozen kan worden|| Actief ingrediënt|| MBH_920_magistraalactieveingredient-TST|| MBH_920_magistraalactieveingredient_MA-TST
 
|-style="vertical-align:top;|style="background-color: white;"
 
|7.3 optioneel|| Maak screenshot(s) waarop zichtbaar is dat het eigen artikel gekozen wordt|| 90 miljoen nummer|| MBH_920_magistraal90miljoennr-TST|| MBH_920_magistraal90miljoennr_MA-TST
 
|}
 
<section end=overview-MGB-7 />
 
=== Scenarioset 8===
 
<section begin=overview-MGB-8 />
 
{| class="wikitable"
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| MA id
 
|-style="vertical-align:top;|style="background-color: white;"
 
|8.1|| Maak screenshot waarop zichtbaar is dat andermans MA in het systeem zit|| Andermans medicatieafspraak (met kopie indicator)|| MBH_920_VVandermansMA-ZTP|| MBH_920_VVandermansMA_MA-ZTP
 
|}
 
<section end=overview-MGB-8 />
 
=== Scenarioset 8i===
 
<section begin=overview-MGB-8i />
 
{| class="wikitable"
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| MA id
 
|-style="vertical-align:top;|style="background-color: white;"
 
|8i.01|| || Andermans medicatieafspraak  ontvangen ter voorbereiding MP-VOS scenario 8.1|| MBH_920_VVandermansMA-ZTP|| MBH_920_VVandermansMA_MA-ZTP
 
|-style="vertical-align:top;|style="background-color: white;"
 
|8i.02|| || Andermans medicatieafspraak  ontvangen ter voorbereiding MP-VOS scenario 8.2|| MBH_920_stakenandermansMA-ZTP|| MBH_920_stakenandermansMA_MA1-ZTP
 
|-style="vertical-align:top;|style="background-color: white;"
 
|8i.03|| || Andermans medicatieafspraak  ontvangen ter voorbereiding MP-VOS scenario 8.3|| MBH_920_onderbrekenandermansMA-ZTP|| MBH_920_onderbrekenandermansMA_MA1-ZTP
 
|-style="vertical-align:top;|style="background-color: white;"
 
|8i.04|| || Andermans medicatieafspraak  ontvangen ter voorbereiding MP-VOS scenario 8.4|| MBH_920_wijzigenandermansMA-ZTP|| MBH_920_wijzigenandermansMA_MA1-ZTP
 
|}
 
<section end=overview-MGB-8i />
 
=== Scenarioset 10===
 
<section begin=overview-MGB-10 />
 
{| class="wikitable"
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| MA id
 
|-style="vertical-align:top;|style="background-color: white;"
 
|10.1 optioneel|| || HPK geneesmiddel|| MBH_920_HPKvoorschrijven-KST|| MBH_920_HPKvoorschrijven_MA-KST
 
|-style="vertical-align:top;|style="background-color: white;"
 
|10.2 optioneel|| || ZI-nr geneesmiddel|| MBH_920_ZINRvoorschrijven-KST|| MBH_920_ZINRvoorschrijven_MA-KST
 
|}
 
<section end=overview-MGB-10 />
 
== Overzicht van scenario's voor ontvangend/raadplegend systeem ==
 
 
 
=== Scenarioset 0===
 
<section begin=overview-MGR-0 />
 
{| class="wikitable"
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
| Scenario|| Beschrijving
 
|-style="vertical-align:top;|style="background-color: white;"
 
|0.1|| Alle medicatieafspraken van de patiënt, zonder aanvullende filter criteria<br/>(Antwoord: bericht met 6 medicatieafspraken)
 
|-style="vertical-align:top;|style="background-color: white;"
 
|0.2|| Specifieke medicatieafspraak met identificaties als filter (in kwalificatiesimulator het id van "MBH_920_QA1_MA" invoeren)<br/>(Antwoord: bericht met 1 medicatieafspraak)
 
|-style="vertical-align:top;|style="background-color: white;"
 
|0.3|| Medicatieafspraken met een filter op product code (PRK 3956)<br/>(Antwoord: bericht met 1 medicatieafspraak)
 
|-style="vertical-align:top;|style="background-color: white;"
 
|0.4|| Medicatieafspraken met een filter op gebruiksperiode – ingangsdatum (alles vanaf T-21)<br/>(Antwoord: bericht met 4 medicatieafspraken)
 
|-style="vertical-align:top;|style="background-color: white;"
 
|0.5|| Medicatieafspraken met een filter op gebruiksperiode – einddatum (alles voor T-22)<br/>(Antwoord: bericht met 3 medicatieafspraken)
 
|-style="vertical-align:top;|style="background-color: white;"
 
|0.6|| Medicatieafspraken met een filter op gebruiksperiode – ingangsdatum én einddatum (alles vanaf T-21 tot en met T-7)<br/>(Antwoord: bericht met 3 medicatieafspraken)
 
|-style="vertical-align:top;|style="background-color: white;"
 
|0.7|| Medicatieafspraken met een specifieke medicamenteuze behandeling als filter (in kwalificatiesimulator het id van "MBH_920_QA1" invoeren)<br/>(Antwoord: bericht met 1 medicatieafspraak)
 
|-style="vertical-align:top;|style="background-color: white;"
 
|0.8|| Een antwoord zonder medicatieafspraken (filter op gebruiksperiode – einddatum (alles voor T-110))<br/>(Antwoord: bericht zonder medicatieafspraken)
 
|}
 
<section end=overview-MGR-0 />
 
=== Scenarioset 1===
 
<section begin=overview-MGR-1 />
 
{| class="wikitable"
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
| Scenario|| Beschrijving|| MBH id|| MA id
 
|-style="vertical-align:top;|style="background-color: white;"
 
|1.1|| Medicatieafspraak gebruiksperiode ingangsdatum en einddatum|| MBH_920_start_eind-BSC|| MBH_920_start_eind_MA-BSC
 
|-style="vertical-align:top;|style="background-color: white;"
 
|1.2a|| Medicatieafspraak gebruiksperiode ingangsdatum en duur (weken)|| MBH_920_start_duur-BSC|| MBH_920_start_duur_MA-BSC
 
|-style="vertical-align:top;|style="background-color: white;"
 
|1.2b|| Medicatieafspraak gebruiksperiode ingangsdatum en duur (dagen)|| MBH_920_start_duur2-BSC|| MBH_920_start_duur2_MA-BSC
 
|-style="vertical-align:top;|style="background-color: white;"
 
|1.3|| Medicatieafspraak gebruiksperiode ingangsdatum (chronische medicatie)|| MBH_920_chronisch-BSC|| MBH_920_chronisch_MA-BSC
 
|-style="vertical-align:top;|style="background-color: white;"
 
|1.4|| Medicatieafspraak met eenheid 'dosis/stuks'|| MBH_920_dosis_stuks-BSC|| MBH_920_dosis_stuks_MA-BSC
 
|}
 
<section end=overview-MGR-1 />
 
=== Scenarioset 2===
 
<section begin=overview-MGR-2 />
 
{| class="wikitable"
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
| Scenario|| Beschrijving|| MBH id|| MA id
 
|-style="vertical-align:top;|style="background-color: white;"
 
|2.1|| Aanvullende instructie|| MBH_920_aanvullendeinstructie-VNK|| MBH_920_aanvullendeinstructie_MA-VNK
 
|-style="vertical-align:top;|style="background-color: white;"
 
|2.2|| Toelichting|| MBH_920_toelichting-VNK|| MBH_920_toelichting_MA-VNK
 
|-style="vertical-align:top;|style="background-color: white;"
 
|2.3|| Reden van voorschrijven|| MBH_920_redenvanvoorschrijven-VNK|| MBH_920_redenvanvoorschrijven_MA-VNK
 
|-style="vertical-align:top;|style="background-color: white;"
 
|2.4|| Aanvullende informatie|| MBH_920_aanvullendeinformatiewensen-VNK|| MBH_920_aanvullendeinformatiewensen_MA-VNK
 
|-style="vertical-align:top;|style="background-color: white;"
 
|2.5|| Toedieningsweg|| MBH_920_Toedieningsweg-VNK|| MBH_920_Toedieningsweg_MA-VNK
 
|}
 
<section end=overview-MGR-2 />
 
=== Scenarioset 3===
 
<section begin=overview-MGR-3 />
 
{| class="wikitable"
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
| Scenario|| Beschrijving|| MBH id|| MA id
 
|-style="vertical-align:top;|style="background-color: white;"
 
|3.1|| Stop-medicatieafspraak, met reden staken<br/>LET OP: stop medicatieafspraak van scenario 2.1|| MBH_920_aanvullendeinstructie-VNK|| MBH_920_aanvullendeinstructie_MA_staken-VNK
 
|-style="vertical-align:top;|style="background-color: white;"
 
|3.2|| Wijziging medicatieafspraak, met reden wijziging (stop-ma + nieuwe ma)<br/>LET OP: wijziging medicatieafspraak van scenario 2.2|| MBH_920_toelichting-VNK|| MBH_920_toelichting_MA_wijzigingmetVV-VNK<br/>MBH_920_toelichting_MA_techstaken-VNK
 
|-style="vertical-align:top;|style="background-color: white;"
 
|3.3|| Wijziging medicatieafspraak, met reden wijziging (stop-ma + nieuwe ma)<br/>LET OP: wijziging medicatieafspraak van scenario 2.3|| MBH_920_redenvanvoorschrijven-VNK|| MBH_920_redenvanvoorschrijven_MA_wijzigingzonderVV-VNK<br/>MBH_920_redenvanvoorschrijven_MA_techstaken-VNK
 
|-style="vertical-align:top;|style="background-color: white;"
 
|3.4|| Onderbreken medicatieafspraak<br/>LET OP: onderbreking medicatieafspraak van scenario 2.4|| MBH_920_aanvullendeinformatiewensen-VNK|| MBH_920_aanvullendeinformatiewensen_MA_onderbreken-VNK
 
|}
 
<section end=overview-MGR-3 />
 
=== Scenarioset 4===
 
<section begin=overview-MGR-4 />
 
{| class="wikitable"
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
| Scenario|| Beschrijving|| MBH id|| MA id
 
|-style="vertical-align:top;|style="background-color: white;"
 
|4.1|| Medicatieafspraak met lengte en gewicht|| MBH_920_Lengte_Gewicht-MLN|| MBH_920_Lengte_Gewicht_MA_1-MLN
 
|}
 
<section end=overview-MGR-4 />
 
=== Scenarioset 6===
 
<section begin=overview-MGR-6 />
 
{| class="wikitable"
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
| Scenario|| Beschrijving|| MBH id|| MA id
 
|-style="vertical-align:top;|style="background-color: white;"
 
|6.1|| Variabele frequentie|| MBH_920_variabelefrequentie-MSZ|| MBH_920_variabelefrequentie_MA-MSZ
 
|-style="vertical-align:top;|style="background-color: white;"
 
|6.2|| Interval|| MBH_920_interval-MSZ|| MBH_920_interval_MA-MSZ
 
|-style="vertical-align:top;|style="background-color: white;"
 
|6.3|| Variabele hoeveelheid (1)|| MBH_920_variabelehoeveelheid-MSZ|| MBH_920_variabelehoeveelheid_MA-MSZ
 
|-style="vertical-align:top;|style="background-color: white;"
 
|6.4|| Zonder keerdosis|| MBH_920_zonderkeerdosis-MSZ|| MBH_920_zonderkeerdosis_MA-MSZ
 
|-style="vertical-align:top;|style="background-color: white;"
 
|6.5|| Bijzondere keerdosis|| MBH_920_bijzonderekeerdosis-MSZ|| MBH_920_bijzonderekeerdosis_MA-MSZ
 
|-style="vertical-align:top;|style="background-color: white;"
 
|6.6|| Variabele hoeveelheid (2)|| MBH_920_variabelehoeveelheid2-MSZ|| MBH_920_variabelehoeveelheid2_MA-MSZ
 
|-style="vertical-align:top;|style="background-color: white;"
 
|6.7|| Tijdstippen|| MBH_920_tijdstippen-MSZ|| MBH_920_tijdstippen_MA-MSZ
 
|-style="vertical-align:top;|style="background-color: white;"
 
|6.8|| Weekdagen|| MBH_920_weekdagen-MSZ|| MBH_920_weekdagen_MA-MSZ
 
|-style="vertical-align:top;|style="background-color: white;"
 
|6.9|| Dagdeel|| MBH_920_dagdeel-MSZ|| MBH_920_dagdeel_MA-MSZ
 
|-style="vertical-align:top;|style="background-color: white;"
 
|6.10|| Cyclisch schema|| MBH_920_cyclischschema-MSZ|| MBH_920_cyclischschema_MA-MSZ
 
|-style="vertical-align:top;|style="background-color: white;"
 
|6.11|| Afbouw schema en doseerduur|| MBH_920_afbouwschema-MSZ|| MBH_920_afbouwschema_MA-MSZ
 
|-style="vertical-align:top;|style="background-color: white;"
 
|6.12|| Variabele hoeveelheid en maximum|| MBH_920_variabelehoeveelheidenmaximum-MSZ|| MBH_920_variabelehoeveelheidenmaximum_MA-MSZ
 
|-style="vertical-align:top;|style="background-color: white;"
 
|6.13|| Toedieningssnelheid|| MBH_920_toedieningssnelheid-MSZ|| MBH_920_toedieningssnelheid_MA-MSZ
 
|-style="vertical-align:top;|style="background-color: white;"
 
|6.14|| Toedieningsduur|| MBH_920_toedieningsduur-MSZ|| MBH_920_toedieningsduur_MA-MSZ
 
|-style="vertical-align:top;|style="background-color: white;"
 
|6.15|| Zo nodig|| MBH_920_zonodig-MSZ|| MBH_920_zonodig_MA-MSZ
 
|}
 
<section end=overview-MGR-6 />
 
=== Scenarioset 7===
 
<section begin=overview-MGR-7 />
 
{| class="wikitable"
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
| Scenario|| Beschrijving|| MBH id|| MA id
 
|-style="vertical-align:top;|style="background-color: white;"
 
|7.1|| Alle ingrediënten|| MBH_920_magistraalalleingredienten-TST|| MBH_920_magistraalalleingredienten_MA-TST
 
|-style="vertical-align:top;|style="background-color: white;"
 
|7.2|| Actief ingrediënt|| MBH_920_magistraalactieveingredient-TST|| MBH_920_magistraalactieveingredient_MA-TST
 
|-style="vertical-align:top;|style="background-color: white;"
 
|7.3|| 90 miljoen nummer|| MBH_920_magistraal90miljoennr-TST|| MBH_920_magistraal90miljoennr_MA-TST
 
|}
 
<section end=overview-MGR-7 />
 
=== Scenarioset 8===
 
<section begin=overview-MGR-8 />
 
{| class="wikitable"
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
| Scenario|| Beschrijving|| MBH id|| MA id
 
|-style="vertical-align:top;|style="background-color: white;"
 
|8.1|| Andermans medicatieafspraak (met kopie indicator)|| MBH_920_VVandermansMA-ZTP|| MBH_920_VVandermansMA_MA-ZTP
 
|}
 
<section end=overview-MGR-8 />
 
=== Scenarioset 8i===
 
<section begin=overview-MGR-8i />
 
{| class="wikitable"
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
| Scenario|| Beschrijving|| MBH id|| MA id
 
|-style="vertical-align:top;|style="background-color: white;"
 
|8i.01|| Andermans medicatieafspraak  ontvangen ter voorbereiding MP-VOS scenario 8.1|| MBH_920_VVandermansMA-ZTP|| MBH_920_VVandermansMA_MA-ZTP
 
|-style="vertical-align:top;|style="background-color: white;"
 
|8i.02|| Andermans medicatieafspraak  ontvangen ter voorbereiding MP-VOS scenario 8.2|| MBH_920_stakenandermansMA-ZTP|| MBH_920_stakenandermansMA_MA1-ZTP
 
|-style="vertical-align:top;|style="background-color: white;"
 
|8i.03|| Andermans medicatieafspraak  ontvangen ter voorbereiding MP-VOS scenario 8.3|| MBH_920_onderbrekenandermansMA-ZTP|| MBH_920_onderbrekenandermansMA_MA1-ZTP
 
|-style="vertical-align:top;|style="background-color: white;"
 
|8i.04|| Andermans medicatieafspraak  ontvangen ter voorbereiding MP-VOS scenario 8.4|| MBH_920_wijzigenandermansMA-ZTP|| MBH_920_wijzigenandermansMA_MA1-ZTP
 
|}
 
<section end=overview-MGR-8i />
 
=== Scenarioset 10===
 
<section begin=overview-MGR-10 />
 
{| class="wikitable"
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
| Scenario|| Beschrijving|| MBH id|| MA id
 
|-style="vertical-align:top;|style="background-color: white;"
 
|10.1|| HPK geneesmiddel|| MBH_920_HPKvoorschrijven-KST|| MBH_920_HPKvoorschrijven_MA-KST
 
|-style="vertical-align:top;|style="background-color: white;"
 
|10.2|| ZI-nr geneesmiddel|| MBH_920_ZINRvoorschrijven-KST|| MBH_920_ZINRvoorschrijven_MA-KST
 
|}
 
<section end=overview-MGR-10 />
 
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 0 (filterqueries)==
 
<section begin=mg-mgr-mg-MA-Scenarioset0-0-1 /><section begin=patient-mg-mgr-mg-MA-Scenarioset0-0-1 />
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="4" width="25%"| Gegevenselement
 
|| Waarde
 
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="5"|Naamgegevens
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="6"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Initialen
 
|style="background-color: white;"|S.
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Geslachtsnaam
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Achternaam
 
|style="background-color: white;"|XXX_Jankie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Identificatienummer
 
|style="background-color: white;"|999910437 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geboortedatum
 
|style="background-color: white;"|8 mei 1954
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
 
|}<section end=patient-mg-mgr-mg-MA-Scenarioset0-0-1 /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset0-0-1 />
 
==== Scenario 0.1 - MBH_920_QA1-JNK====
 
 
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_QA1_MA-JNK
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="3" width="25%"| Gegevenselement
 
|| Waarde
 
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|style="background-color: white;"|MBH_920_QA1_MA-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Medicatieafspraak datum tijd
 
|style="background-color: white;"|T - 20 dagen om 08:00 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="3"|Gebruiksperiode
 
|style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, tot en met T + 9 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|style="background-color: white;"|T - 20 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Einddatum
 
|style="background-color: white;"|T + 9 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Voorschrijver
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgverlener
 
|style="background-color: white;"|Zie [[#d4e23|Zorgverlener: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Farmaceutisch product
 
|style="background-color: white;"|Zie [[#d4e42|Farmaceutisch product: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|style="background-color: white;"|Vanaf T - 20 dagen, tot en met T + 9 dagen, 1 maal per dag 2 stuks, Oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|style="background-color: white;"|1 maal per dag 2 stuks
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|style="background-color: white;"|MBH_920_QA1-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
==== Scenario 0.1 - MBH_920_QA2-JNK====
 
 
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_QA2_MA-JNK
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="3" width="25%"| Gegevenselement
 
|| Waarde
 
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|style="background-color: white;"|MBH_920_QA2_MA-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Medicatieafspraak datum tijd
 
|style="background-color: white;"|T - 100 dagen om 08:04 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="3"|Gebruiksperiode
 
|style="background-color: #E3E3E3;;"|''Vanaf T - 100 dagen, tot en met T - 72 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|style="background-color: white;"|T - 100 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Einddatum
 
|style="background-color: white;"|T - 72 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Voorschrijver
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgverlener
 
|style="background-color: white;"|Zie [[#d4e204|Zorgverlener: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Farmaceutisch product
 
|style="background-color: white;"|Zie [[#d4e223|Farmaceutisch product: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|style="background-color: white;"|Vanaf T - 100 dagen, tot en met T - 72 dagen, 1 maal per dag 10 ml, oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|style="background-color: white;"|1 maal per dag 10 ml
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|style="background-color: white;"|MBH_920_QA2-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
==== Scenario 0.1 - MBH_920_QA3-JNK====
 
 
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_QA3_MA-JNK
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="3" width="25%"| Gegevenselement
 
|| Waarde
 
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|style="background-color: white;"|MBH_920_QA3_MA-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Medicatieafspraak datum tijd
 
|style="background-color: white;"|T - 50 dagen om 08:10 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="3"|Gebruiksperiode
 
|style="background-color: #E3E3E3;;"|''Vanaf T - 50 dagen, tot en met T - 11 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|style="background-color: white;"|T - 50 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Einddatum
 
|style="background-color: white;"|T - 11 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Voorschrijver
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgverlener
 
|style="background-color: white;"|Zie [[#d4e399|Zorgverlener: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Farmaceutisch product
 
|style="background-color: white;"|Zie [[#d4e418|Farmaceutisch product: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|style="background-color: white;"|Vanaf T - 50 dagen, tot en met T - 11 dagen, 2 maal per dag 50 ml, oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|style="background-color: white;"|2 maal per dag 50 ml
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|style="background-color: white;"|MBH_920_QA3-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
==== Scenario 0.1 - MBH_920_QA4-JNK====
 
 
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_QA4_MA-JNK
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="3" width="25%"| Gegevenselement
 
|| Waarde
 
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|style="background-color: white;"|MBH_920_QA4_MA-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Medicatieafspraak datum tijd
 
|style="background-color: white;"|T - 10 dagen om 08:12 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="3"|Gebruiksperiode
 
|style="background-color: #E3E3E3;;"|''Vanaf T - 10 dagen, tot en met T + 19 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|style="background-color: white;"|T - 10 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Einddatum
 
|style="background-color: white;"|T + 19 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Voorschrijver
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgverlener
 
|style="background-color: white;"|Zie [[#d4e583|Zorgverlener: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Farmaceutisch product
 
|style="background-color: white;"|Zie [[#d4e602|Farmaceutisch product: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|style="background-color: white;"|Vanaf T - 10 dagen, tot en met T + 19 dagen, 1 maal per dag 3 stuks, oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|style="background-color: white;"|1 maal per dag 3 stuks
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|style="background-color: white;"|MBH_920_QA4-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
==== Scenario 0.1 - MBH_920_QA5-JNK====
 
 
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_QA5_MA-JNK
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="3" width="25%"| Gegevenselement
 
|| Waarde
 
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|style="background-color: white;"|MBH_920_QA5_MA-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Medicatieafspraak datum tijd
 
|style="background-color: white;"|T - 50 dagen om 08:15 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="3"|Gebruiksperiode
 
|style="background-color: #E3E3E3;;"|''Vanaf T - 50 dagen, gedurende 7 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|style="background-color: white;"|T - 50 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Gebruiksduur
 
|style="background-color: white;"|7 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Voorschrijver
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgverlener
 
|style="background-color: white;"|Zie [[#d4e764|Zorgverlener: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Farmaceutisch product
 
|style="background-color: white;"|Zie [[#d4e783|Farmaceutisch product: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|style="background-color: white;"|Vanaf T - 50 dagen, gedurende 7 dagen, 1 maal per dag 1 stuk, oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|style="background-color: white;"|1 maal per dag 1 stuk
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|style="background-color: white;"|MBH_920_QA5-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
==== Scenario 0.1 - MBH_920_QA6-JNK====
 
 
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_QA6_MA-JNK
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="3" width="25%"| Gegevenselement
 
|| Waarde
 
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|style="background-color: white;"|MBH_920_QA6_MA-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Medicatieafspraak datum tijd
 
|style="background-color: white;"|T - 5 dagen om 08:18 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="3"|Gebruiksperiode
 
|style="background-color: #E3E3E3;;"|''Vanaf T - 5 dagen, tot en met T + 1 dag''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|style="background-color: white;"|T - 5 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Einddatum
 
|style="background-color: white;"|T + 1 dag
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Voorschrijver
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgverlener
 
|style="background-color: white;"|Zie [[#d4e945|Zorgverlener: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Farmaceutisch product
 
|style="background-color: white;"|Zie [[#d4e964|Farmaceutisch product: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|style="background-color: white;"|Vanaf T - 5 dagen, tot en met T + 1 dag, 2 maal per dag 2 stuks, oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|style="background-color: white;"|2 maal per dag 2 stuks
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|style="background-color: white;"|MBH_920_QA6-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset0-0-1 /><section end=mg-mgr-mg-MA-Scenarioset0-0-1 />
 
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 0 (filterqueries)==
 
<section begin=mg-mgr-mg-MA-Scenarioset0-0-2 /><section begin=patient-mg-mgr-mg-MA-Scenarioset0-0-2 />
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="4" width="25%"| Gegevenselement
 
|| Waarde
 
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="5"|Naamgegevens
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="6"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Initialen
 
|style="background-color: white;"|S.
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Geslachtsnaam
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Achternaam
 
|style="background-color: white;"|XXX_Jankie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Identificatienummer
 
|style="background-color: white;"|999910437 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geboortedatum
 
|style="background-color: white;"|8 mei 1954
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
 
|}<section end=patient-mg-mgr-mg-MA-Scenarioset0-0-2 /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset0-0-2 />
 
==== Scenario 0.2 - MBH_920_QA1-JNK====
 
 
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_QA1_MA-JNK
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="3" width="25%"| Gegevenselement
 
|| Waarde
 
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|style="background-color: white;"|MBH_920_QA1_MA-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Medicatieafspraak datum tijd
 
|style="background-color: white;"|T - 20 dagen om 08:00 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="3"|Gebruiksperiode
 
|style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, tot en met T + 9 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|style="background-color: white;"|T - 20 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Einddatum
 
|style="background-color: white;"|T + 9 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Voorschrijver
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgverlener
 
|style="background-color: white;"|Zie [[#d4e23|Zorgverlener: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Farmaceutisch product
 
|style="background-color: white;"|Zie [[#d4e42|Farmaceutisch product: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|style="background-color: white;"|Vanaf T - 20 dagen, tot en met T + 9 dagen, 1 maal per dag 2 stuks, Oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|style="background-color: white;"|1 maal per dag 2 stuks
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|style="background-color: white;"|MBH_920_QA1-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset0-0-2 /><section end=mg-mgr-mg-MA-Scenarioset0-0-2 />
 
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 0 (filterqueries)==
 
<section begin=mg-mgr-mg-MA-Scenarioset0-0-3optioneel /><section begin=patient-mg-mgr-mg-MA-Scenarioset0-0-3optioneel />
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="4" width="25%"| Gegevenselement
 
|| Waarde
 
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="5"|Naamgegevens
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="6"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Initialen
 
|style="background-color: white;"|S.
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Geslachtsnaam
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Achternaam
 
|style="background-color: white;"|XXX_Jankie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Identificatienummer
 
|style="background-color: white;"|999910437 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geboortedatum
 
|style="background-color: white;"|8 mei 1954
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
 
|}<section end=patient-mg-mgr-mg-MA-Scenarioset0-0-3optioneel /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset0-0-3optioneel />
 
==== Scenario 0.3 - MBH_920_QA4-JNK====
 
 
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_QA4_MA-JNK
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="3" width="25%"| Gegevenselement
 
|| Waarde
 
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|style="background-color: white;"|MBH_920_QA4_MA-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Medicatieafspraak datum tijd
 
|style="background-color: white;"|T - 10 dagen om 08:12 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="3"|Gebruiksperiode
 
|style="background-color: #E3E3E3;;"|''Vanaf T - 10 dagen, tot en met T + 19 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|style="background-color: white;"|T - 10 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Einddatum
 
|style="background-color: white;"|T + 19 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Voorschrijver
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgverlener
 
|style="background-color: white;"|Zie [[#d4e583|Zorgverlener: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Farmaceutisch product
 
|style="background-color: white;"|Zie [[#d4e602|Farmaceutisch product: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|style="background-color: white;"|Vanaf T - 10 dagen, tot en met T + 19 dagen, 1 maal per dag 3 stuks, oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|style="background-color: white;"|1 maal per dag 3 stuks
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|style="background-color: white;"|MBH_920_QA4-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset0-0-3optioneel /><section end=mg-mgr-mg-MA-Scenarioset0-0-3optioneel />
 
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 0 (filterqueries)==
 
<section begin=mg-mgr-mg-MA-Scenarioset0-0-4 /><section begin=patient-mg-mgr-mg-MA-Scenarioset0-0-4 />
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="4" width="25%"| Gegevenselement
 
|| Waarde
 
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="5"|Naamgegevens
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="6"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Initialen
 
|style="background-color: white;"|S.
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Geslachtsnaam
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Achternaam
 
|style="background-color: white;"|XXX_Jankie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Identificatienummer
 
|style="background-color: white;"|999910437 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geboortedatum
 
|style="background-color: white;"|8 mei 1954
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
 
|}<section end=patient-mg-mgr-mg-MA-Scenarioset0-0-4 /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset0-0-4 />
 
==== Scenario 0.4 - MBH_920_QA1-JNK====
 
 
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_QA1_MA-JNK
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="3" width="25%"| Gegevenselement
 
|| Waarde
 
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|style="background-color: white;"|MBH_920_QA1_MA-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Medicatieafspraak datum tijd
 
|style="background-color: white;"|T - 20 dagen om 08:00 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="3"|Gebruiksperiode
 
|style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, tot en met T + 9 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|style="background-color: white;"|T - 20 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Einddatum
 
|style="background-color: white;"|T + 9 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Voorschrijver
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgverlener
 
|style="background-color: white;"|Zie [[#d4e23|Zorgverlener: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Farmaceutisch product
 
|style="background-color: white;"|Zie [[#d4e42|Farmaceutisch product: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|style="background-color: white;"|Vanaf T - 20 dagen, tot en met T + 9 dagen, 1 maal per dag 2 stuks, Oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|style="background-color: white;"|1 maal per dag 2 stuks
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|style="background-color: white;"|MBH_920_QA1-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
 
|}
 
|}
==== Scenario 0.4 - MBH_920_QA3-JNK====
 
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_QA3_MA-JNK
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="3" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|style="background-color: white;"|MBH_920_QA3_MA-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Medicatieafspraak datum tijd
 
|style="background-color: white;"|T - 50 dagen om 08:10 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="3"|Gebruiksperiode
 
|style="background-color: #E3E3E3;;"|''Vanaf T - 50 dagen, tot en met T - 11 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|style="background-color: white;"|T - 50 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Einddatum
 
|style="background-color: white;"|T - 11 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Voorschrijver
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgverlener
 
|style="background-color: white;"|Zie [[#d4e399|Zorgverlener: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Farmaceutisch product
 
|style="background-color: white;"|Zie [[#d4e418|Farmaceutisch product: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|style="background-color: white;"|Vanaf T - 50 dagen, tot en met T - 11 dagen, 2 maal per dag 50 ml, oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|style="background-color: white;"|2 maal per dag 50 ml
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|style="background-color: white;"|MBH_920_QA3-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
==== Scenario 0.4 - MBH_920_QA4-JNK====
 
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_QA4_MA-JNK
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="3" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|style="background-color: white;"|MBH_920_QA4_MA-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Medicatieafspraak datum tijd
 
|style="background-color: white;"|T - 10 dagen om 08:12 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="3"|Gebruiksperiode
 
|style="background-color: #E3E3E3;;"|''Vanaf T - 10 dagen, tot en met T + 19 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|style="background-color: white;"|T - 10 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Einddatum
 
|style="background-color: white;"|T + 19 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Voorschrijver
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgverlener
 
|style="background-color: white;"|Zie [[#d4e583|Zorgverlener: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Farmaceutisch product
 
|style="background-color: white;"|Zie [[#d4e602|Farmaceutisch product: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|style="background-color: white;"|Vanaf T - 10 dagen, tot en met T + 19 dagen, 1 maal per dag 3 stuks, oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|style="background-color: white;"|1 maal per dag 3 stuks
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|style="background-color: white;"|MBH_920_QA4-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
==== Scenario 0.4 - MBH_920_QA6-JNK====
 
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_QA6_MA-JNK
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="3" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|style="background-color: white;"|MBH_920_QA6_MA-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Medicatieafspraak datum tijd
 
|style="background-color: white;"|T - 5 dagen om 08:18 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="3"|Gebruiksperiode
 
|style="background-color: #E3E3E3;;"|''Vanaf T - 5 dagen, tot en met T + 1 dag''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|style="background-color: white;"|T - 5 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Einddatum
 
|style="background-color: white;"|T + 1 dag
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Voorschrijver
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgverlener
 
|style="background-color: white;"|Zie [[#d4e945|Zorgverlener: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Farmaceutisch product
 
|style="background-color: white;"|Zie [[#d4e964|Farmaceutisch product: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|style="background-color: white;"|Vanaf T - 5 dagen, tot en met T + 1 dag, 2 maal per dag 2 stuks, oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|style="background-color: white;"|2 maal per dag 2 stuks
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|style="background-color: white;"|MBH_920_QA6-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset0-0-4 /><section end=mg-mgr-mg-MA-Scenarioset0-0-4 />
 
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 0 (filterqueries)==
 
<section begin=mg-mgr-mg-MA-Scenarioset0-0-5 /><section begin=patient-mg-mgr-mg-MA-Scenarioset0-0-5 />
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="4" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="5"|Naamgegevens
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="6"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Initialen
 
|style="background-color: white;"|S.
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Geslachtsnaam
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Achternaam
 
|style="background-color: white;"|XXX_Jankie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Identificatienummer
 
|style="background-color: white;"|999910437 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geboortedatum
 
|style="background-color: white;"|8 mei 1954
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
 
|}<section end=patient-mg-mgr-mg-MA-Scenarioset0-0-5 /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset0-0-5 />
 
==== Scenario 0.5 - MBH_920_QA2-JNK====
 
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_QA2_MA-JNK
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="3" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|style="background-color: white;"|MBH_920_QA2_MA-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Medicatieafspraak datum tijd
 
|style="background-color: white;"|T - 100 dagen om 08:04 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="3"|Gebruiksperiode
 
|style="background-color: #E3E3E3;;"|''Vanaf T - 100 dagen, tot en met T - 72 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|style="background-color: white;"|T - 100 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Einddatum
 
|style="background-color: white;"|T - 72 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Voorschrijver
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgverlener
 
|style="background-color: white;"|Zie [[#d4e204|Zorgverlener: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Farmaceutisch product
 
|style="background-color: white;"|Zie [[#d4e223|Farmaceutisch product: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|style="background-color: white;"|Vanaf T - 100 dagen, tot en met T - 72 dagen, 1 maal per dag 10 ml, oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|style="background-color: white;"|1 maal per dag 10 ml
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|style="background-color: white;"|MBH_920_QA2-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
==== Scenario 0.5 - MBH_920_QA3-JNK====
 
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_QA3_MA-JNK
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="3" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|style="background-color: white;"|MBH_920_QA3_MA-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Medicatieafspraak datum tijd
 
|style="background-color: white;"|T - 50 dagen om 08:10 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="3"|Gebruiksperiode
 
|style="background-color: #E3E3E3;;"|''Vanaf T - 50 dagen, tot en met T - 11 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|style="background-color: white;"|T - 50 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Einddatum
 
|style="background-color: white;"|T - 11 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Voorschrijver
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgverlener
 
|style="background-color: white;"|Zie [[#d4e399|Zorgverlener: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Farmaceutisch product
 
|style="background-color: white;"|Zie [[#d4e418|Farmaceutisch product: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|style="background-color: white;"|Vanaf T - 50 dagen, tot en met T - 11 dagen, 2 maal per dag 50 ml, oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|style="background-color: white;"|2 maal per dag 50 ml
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|style="background-color: white;"|MBH_920_QA3-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
==== Scenario 0.5 - MBH_920_QA5-JNK====
 
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_QA5_MA-JNK
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="3" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|style="background-color: white;"|MBH_920_QA5_MA-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Medicatieafspraak datum tijd
 
|style="background-color: white;"|T - 50 dagen om 08:15 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="3"|Gebruiksperiode
 
|style="background-color: #E3E3E3;;"|''Vanaf T - 50 dagen, gedurende 7 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|style="background-color: white;"|T - 50 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Gebruiksduur
 
|style="background-color: white;"|7 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Voorschrijver
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgverlener
 
|style="background-color: white;"|Zie [[#d4e764|Zorgverlener: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Farmaceutisch product
 
|style="background-color: white;"|Zie [[#d4e783|Farmaceutisch product: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|style="background-color: white;"|Vanaf T - 50 dagen, gedurende 7 dagen, 1 maal per dag 1 stuk, oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|style="background-color: white;"|1 maal per dag 1 stuk
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|style="background-color: white;"|MBH_920_QA5-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset0-0-5 /><section end=mg-mgr-mg-MA-Scenarioset0-0-5 />
 
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 0 (filterqueries)==
 
<section begin=mg-mgr-mg-MA-Scenarioset0-0-6 /><section begin=patient-mg-mgr-mg-MA-Scenarioset0-0-6 />
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="4" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="5"|Naamgegevens
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="6"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Initialen
 
|style="background-color: white;"|S.
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Geslachtsnaam
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Achternaam
 
|style="background-color: white;"|XXX_Jankie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Identificatienummer
 
|style="background-color: white;"|999910437 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geboortedatum
 
|style="background-color: white;"|8 mei 1954
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
 
|}<section end=patient-mg-mgr-mg-MA-Scenarioset0-0-6 /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset0-0-6 />
 
==== Scenario 0.6 - MBH_920_QA1-JNK====
 
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_QA1_MA-JNK
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="3" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|style="background-color: white;"|MBH_920_QA1_MA-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Medicatieafspraak datum tijd
 
|style="background-color: white;"|T - 20 dagen om 08:00 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="3"|Gebruiksperiode
 
|style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, tot en met T + 9 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|style="background-color: white;"|T - 20 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Einddatum
 
|style="background-color: white;"|T + 9 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Voorschrijver
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgverlener
 
|style="background-color: white;"|Zie [[#d4e23|Zorgverlener: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Farmaceutisch product
 
|style="background-color: white;"|Zie [[#d4e42|Farmaceutisch product: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|style="background-color: white;"|Vanaf T - 20 dagen, tot en met T + 9 dagen, 1 maal per dag 2 stuks, Oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|style="background-color: white;"|1 maal per dag 2 stuks
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|style="background-color: white;"|MBH_920_QA1-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
==== Scenario 0.6 - MBH_920_QA3-JNK====
 
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_QA3_MA-JNK
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="3" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|style="background-color: white;"|MBH_920_QA3_MA-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Medicatieafspraak datum tijd
 
|style="background-color: white;"|T - 50 dagen om 08:10 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="3"|Gebruiksperiode
 
|style="background-color: #E3E3E3;;"|''Vanaf T - 50 dagen, tot en met T - 11 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|style="background-color: white;"|T - 50 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Einddatum
 
|style="background-color: white;"|T - 11 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Voorschrijver
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgverlener
 
|style="background-color: white;"|Zie [[#d4e399|Zorgverlener: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Farmaceutisch product
 
|style="background-color: white;"|Zie [[#d4e418|Farmaceutisch product: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|style="background-color: white;"|Vanaf T - 50 dagen, tot en met T - 11 dagen, 2 maal per dag 50 ml, oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|style="background-color: white;"|2 maal per dag 50 ml
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|style="background-color: white;"|MBH_920_QA3-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
==== Scenario 0.6 - MBH_920_QA4-JNK====
 
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_QA4_MA-JNK
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="3" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|style="background-color: white;"|MBH_920_QA4_MA-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Medicatieafspraak datum tijd
 
|style="background-color: white;"|T - 10 dagen om 08:12 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="3"|Gebruiksperiode
 
|style="background-color: #E3E3E3;;"|''Vanaf T - 10 dagen, tot en met T + 19 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|style="background-color: white;"|T - 10 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Einddatum
 
|style="background-color: white;"|T + 19 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Voorschrijver
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgverlener
 
|style="background-color: white;"|Zie [[#d4e583|Zorgverlener: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Farmaceutisch product
 
|style="background-color: white;"|Zie [[#d4e602|Farmaceutisch product: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|style="background-color: white;"|Vanaf T - 10 dagen, tot en met T + 19 dagen, 1 maal per dag 3 stuks, oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|style="background-color: white;"|1 maal per dag 3 stuks
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|style="background-color: white;"|MBH_920_QA4-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset0-0-6 /><section end=mg-mgr-mg-MA-Scenarioset0-0-6 />
 
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 0 (filterqueries)==
 
<section begin=mg-mgr-mg-MA-Scenarioset0-0-7 /><section begin=patient-mg-mgr-mg-MA-Scenarioset0-0-7 />
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="4" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="5"|Naamgegevens
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="6"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Initialen
 
|style="background-color: white;"|S.
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Geslachtsnaam
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Achternaam
 
|style="background-color: white;"|XXX_Jankie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Identificatienummer
 
|style="background-color: white;"|999910437 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geboortedatum
 
|style="background-color: white;"|8 mei 1954
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
 
|}<section end=patient-mg-mgr-mg-MA-Scenarioset0-0-7 /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset0-0-7 />
 
==== Scenario 0.7 - MBH_920_QA1-JNK====
 
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_QA1_MA-JNK
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="3" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|style="background-color: white;"|MBH_920_QA1_MA-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Medicatieafspraak datum tijd
 
|style="background-color: white;"|T - 20 dagen om 08:00 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="3"|Gebruiksperiode
 
|style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, tot en met T + 9 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|style="background-color: white;"|T - 20 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Einddatum
 
|style="background-color: white;"|T + 9 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Voorschrijver
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgverlener
 
|style="background-color: white;"|Zie [[#d4e23|Zorgverlener: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Farmaceutisch product
 
|style="background-color: white;"|Zie [[#d4e42|Farmaceutisch product: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|style="background-color: white;"|Vanaf T - 20 dagen, tot en met T + 9 dagen, 1 maal per dag 2 stuks, Oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|style="background-color: white;"|1 maal per dag 2 stuks
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|style="background-color: white;"|MBH_920_QA1-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset0-0-7 /><section end=mg-mgr-mg-MA-Scenarioset0-0-7 />
 
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 0 (filterqueries)==
 
<section begin=mg-mgr-mg-MA-Scenarioset0-0-8 /><section begin=patient-mg-mgr-mg-MA-Scenarioset0-0-8 />
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="4" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="5"|Naamgegevens
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="6"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Initialen
 
|style="background-color: white;"|S.
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Geslachtsnaam
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Achternaam
 
|style="background-color: white;"|XXX_Jankie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Identificatienummer
 
|style="background-color: white;"|999910437 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geboortedatum
 
|style="background-color: white;"|8 mei 1954
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
 
|}<section end=patient-mg-mgr-mg-MA-Scenarioset0-0-8 /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset0-0-8 /><section end=mbhs-mg-mgr-mg-MA-Scenarioset0-0-8 /><section end=mg-mgr-mg-MA-Scenarioset0-0-8 />
 
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 1==
 
<section begin=mg-mgr-mg-MA-Scenarioset1-1-1 /><section begin=patient-mg-mgr-mg-MA-Scenarioset1-1-1 />
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="4" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="5"|Naamgegevens
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="7"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Initialen
 
|style="background-color: white;"|A.
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Geslachtsnaam
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Voorvoegsels
 
|style="background-color: white;"|van de
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Achternaam
 
|style="background-color: white;"|XXX_Boschman
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Identificatienummer
 
|style="background-color: white;"|999912100 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geboortedatum
 
|style="background-color: white;"|8 jan 1964
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
 
|}<section end=patient-mg-mgr-mg-MA-Scenarioset1-1-1 /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset1-1-1 />
 
==== Scenario 1.1 - MBH_920_start_eind-BSC====
 
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_start_eind_MA-BSC
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="3" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|style="background-color: white;"|MBH_920_start_eind_MA-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Medicatieafspraak datum tijd
 
|style="background-color: white;"|T om 11:20 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="3"|Gebruiksperiode
 
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 5 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|style="background-color: white;"|T
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Einddatum
 
|style="background-color: white;"|T + 5 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Voorschrijver
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgverlener
 
|style="background-color: white;"|Zie [[#d4e24|Zorgverlener: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Farmaceutisch product
 
|style="background-color: white;"|Zie [[#d4e43|Farmaceutisch product: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|style="background-color: white;"|Vanaf T, tot en met T + 5 dagen, 1 maal per dag 1 stuk, Oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|style="background-color: white;"|1 maal per dag 1 stuk
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|style="background-color: white;"|MBH_920_start_eind-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset1-1-1 /><section end=mg-mgr-mg-MA-Scenarioset1-1-1 />
 
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 1==
 
<section begin=mg-mgr-mg-MA-Scenarioset1-1-2a /><section begin=patient-mg-mgr-mg-MA-Scenarioset1-1-2a />
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="4" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="5"|Naamgegevens
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="7"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Initialen
 
|style="background-color: white;"|A.
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Geslachtsnaam
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Voorvoegsels
 
|style="background-color: white;"|van de
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Achternaam
 
|style="background-color: white;"|XXX_Boschman
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Identificatienummer
 
|style="background-color: white;"|999912100 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geboortedatum
 
|style="background-color: white;"|8 jan 1964
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
 
|}<section end=patient-mg-mgr-mg-MA-Scenarioset1-1-2a /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset1-1-2a />
 
==== Scenario 1.2a - MBH_920_start_duur-BSC====
 
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_start_duur_MA-BSC
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="3" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|style="background-color: white;"|MBH_920_start_duur_MA-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Medicatieafspraak datum tijd
 
|style="background-color: white;"|T om 11:30 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="3"|Gebruiksperiode
 
|style="background-color: #E3E3E3;;"|''Vanaf T, gedurende 3 weken''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|style="background-color: white;"|T
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Gebruiksduur
 
|style="background-color: white;"|3 weken
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Voorschrijver
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgverlener
 
|style="background-color: white;"|Zie [[#d4e204|Zorgverlener: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Farmaceutisch product
 
|style="background-color: white;"|Zie [[#d4e223|Farmaceutisch product: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|style="background-color: white;"|Vanaf T, gedurende 3 weken, 1 maal per dag 1 stuk, Oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|style="background-color: white;"|1 maal per dag 1 stuk
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|style="background-color: white;"|MBH_920_start_duur-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset1-1-2a /><section end=mg-mgr-mg-MA-Scenarioset1-1-2a />
 
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 1==
 
<section begin=mg-mgr-mg-MA-Scenarioset1-1-2b /><section begin=patient-mg-mgr-mg-MA-Scenarioset1-1-2b />
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="4" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="5"|Naamgegevens
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="7"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Initialen
 
|style="background-color: white;"|A.
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Geslachtsnaam
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Voorvoegsels
 
|style="background-color: white;"|van de
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Achternaam
 
|style="background-color: white;"|XXX_Boschman
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Identificatienummer
 
|style="background-color: white;"|999912100 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geboortedatum
 
|style="background-color: white;"|8 jan 1964
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
 
|}<section end=patient-mg-mgr-mg-MA-Scenarioset1-1-2b /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset1-1-2b />
 
==== Scenario 1.2b - MBH_920_start_duur2-BSC====
 
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_start_duur2_MA-BSC
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="3" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|style="background-color: white;"|MBH_920_start_duur2_MA-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Medicatieafspraak datum tijd
 
|style="background-color: white;"|T - 60 dagen om 11:30 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="3"|Gebruiksperiode
 
|style="background-color: #E3E3E3;;"|''Vanaf T - 60 dagen, gedurende 28 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|style="background-color: white;"|T - 60 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Gebruiksduur
 
|style="background-color: white;"|28 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Voorschrijver
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgverlener
 
|style="background-color: white;"|Zie [[#d4e621|Zorgverlener: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Farmaceutisch product
 
|style="background-color: white;"|Zie [[#d4e640|Farmaceutisch product: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|style="background-color: white;"|Vanaf T - 60 dagen, gedurende 28 dagen, 1 maal per dag 1 stuk, Oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|style="background-color: white;"|1 maal per dag 1 stuk
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|style="background-color: white;"|MBH_920_start_duur2-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset1-1-2b /><section end=mg-mgr-mg-MA-Scenarioset1-1-2b />
 
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 1==
 
<section begin=mg-mgr-mg-MA-Scenarioset1-1-3 /><section begin=patient-mg-mgr-mg-MA-Scenarioset1-1-3 />
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="4" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="5"|Naamgegevens
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="7"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Initialen
 
|style="background-color: white;"|A.
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Geslachtsnaam
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Voorvoegsels
 
|style="background-color: white;"|van de
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Achternaam
 
|style="background-color: white;"|XXX_Boschman
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Identificatienummer
 
|style="background-color: white;"|999912100 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geboortedatum
 
|style="background-color: white;"|8 jan 1964
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
 
|}<section end=patient-mg-mgr-mg-MA-Scenarioset1-1-3 /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset1-1-3 />
 
==== Scenario 1.3 - MBH_920_chronisch-BSC====
 
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_chronisch_MA-BSC
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="3" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|style="background-color: white;"|MBH_920_chronisch_MA-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Medicatieafspraak datum tijd
 
|style="background-color: white;"|T - 30 dagen om 11:32 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="3"|Gebruiksperiode
 
|style="background-color: #E3E3E3;;"|''Vanaf T - 30 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|style="background-color: white;"|T - 30 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Voorschrijver
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgverlener
 
|style="background-color: white;"|Zie [[#d4e387|Zorgverlener: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Farmaceutisch product
 
|style="background-color: white;"|Zie [[#d4e406|Farmaceutisch product: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|style="background-color: white;"|Vanaf T - 30 dagen, 1 maal per dag 1 stuk, Oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|style="background-color: white;"|1 maal per dag 1 stuk
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|style="background-color: white;"|MBH_920_chronisch-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset1-1-3 /><section end=mg-mgr-mg-MA-Scenarioset1-1-3 />
 
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 1==
 
<section begin=mg-mgr-mg-MA-Scenarioset1-1-4 /><section begin=patient-mg-mgr-mg-MA-Scenarioset1-1-4 />
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="4" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="5"|Naamgegevens
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="7"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Initialen
 
|style="background-color: white;"|A.
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Geslachtsnaam
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Voorvoegsels
 
|style="background-color: white;"|van de
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Achternaam
 
|style="background-color: white;"|XXX_Boschman
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Identificatienummer
 
|style="background-color: white;"|999912100 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geboortedatum
 
|style="background-color: white;"|8 jan 1964
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
 
|}<section end=patient-mg-mgr-mg-MA-Scenarioset1-1-4 /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset1-1-4 />
 
==== Scenario 1.4 - MBH_920_dosis_stuks-BSC====
 
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_dosis_stuks_MA-BSC
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="3" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|style="background-color: white;"|MBH_920_dosis_stuks_MA-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Medicatieafspraak datum tijd
 
|style="background-color: white;"|T - 130 dagen om 11:35 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="3"|Gebruiksperiode
 
|style="background-color: #E3E3E3;;"|''Vanaf T - 130 dagen, tot en met T - 101 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|style="background-color: white;"|T - 130 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Einddatum
 
|style="background-color: white;"|T - 101 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Voorschrijver
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgverlener
 
|style="background-color: white;"|Zie [[#d4e887|Zorgverlener: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Farmaceutisch product
 
|style="background-color: white;"|Zie [[#d4e906|Farmaceutisch product: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|style="background-color: white;"|Vanaf T - 130 dagen, tot en met T - 101 dagen, 2 maal per dag 1 dosis, inhalatie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|style="background-color: white;"|inhalatie (code = '62' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|style="background-color: white;"|2 maal per dag 1 dosis
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|style="background-color: white;"|MBH_920_dosis_stuks-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset1-1-4 /><section end=mg-mgr-mg-MA-Scenarioset1-1-4 />
 
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 2==
 
<section begin=mg-mgr-mg-MA-Scenarioset2-2-1 /><section begin=patient-mg-mgr-mg-MA-Scenarioset2-2-1 />
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="4" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="5"|Naamgegevens
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="6"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Initialen
 
|style="background-color: white;"|C.
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Geslachtsnaam
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Achternaam
 
|style="background-color: white;"|XXX_Vonker
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Identificatienummer
 
|style="background-color: white;"|999910401 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geboortedatum
 
|style="background-color: white;"|8 feb 1954
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
 
|}<section end=patient-mg-mgr-mg-MA-Scenarioset2-2-1 /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset2-2-1 />
 
==== Scenario 2.1 - MBH_920_aanvullendeinstructie-VNK====
 
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_aanvullendeinstructie_MA-VNK
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="3" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|style="background-color: white;"|MBH_920_aanvullendeinstructie_MA-VNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Medicatieafspraak datum tijd
 
|style="background-color: white;"|T - 4 maanden om 08:00 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="3"|Gebruiksperiode
 
|style="background-color: #E3E3E3;;"|''Vanaf T - 4 maanden, tot en met T + 8 maanden''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|style="background-color: white;"|T - 4 maanden
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Einddatum
 
|style="background-color: white;"|T + 8 maanden
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Voorschrijver
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgverlener
 
|style="background-color: white;"|Zie [[#d4e23|Zorgverlener: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Farmaceutisch product
 
|style="background-color: white;"|Zie [[#d4e42|Farmaceutisch product: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="5"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|style="background-color: white;"|Vanaf T - 4 maanden, tot en met T + 8 maanden, 1 maal per dag 1 stuk, Bij het eten innemen, Oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Aanvullende instructie
 
|style="background-color: white;"|overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Bij het eten innemen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|style="background-color: white;"|1 maal per dag 1 stuk
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|style="background-color: white;"|MBH_920_aanvullendeinstructie-VNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset2-2-1 /><section end=mg-mgr-mg-MA-Scenarioset2-2-1 />
 
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 2==
 
<section begin=mg-mgr-mg-MA-Scenarioset2-2-2 /><section begin=patient-mg-mgr-mg-MA-Scenarioset2-2-2 />
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="4" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="5"|Naamgegevens
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="6"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Initialen
 
|style="background-color: white;"|C.
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Geslachtsnaam
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Achternaam
 
|style="background-color: white;"|XXX_Vonker
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Identificatienummer
 
|style="background-color: white;"|999910401 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geboortedatum
 
|style="background-color: white;"|8 feb 1954
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
 
|}<section end=patient-mg-mgr-mg-MA-Scenarioset2-2-2 /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset2-2-2 />
 
==== Scenario 2.2 - MBH_920_toelichting-VNK====
 
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_toelichting_MA-VNK
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="3" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|style="background-color: white;"|MBH_920_toelichting_MA-VNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Medicatieafspraak datum tijd
 
|style="background-color: white;"|T - 21 dagen om 08:02 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="3"|Gebruiksperiode
 
|style="background-color: #E3E3E3;;"|''Vanaf T - 21 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|style="background-color: white;"|T - 21 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Voorschrijver
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgverlener
 
|style="background-color: white;"|Zie [[#d4e150|Zorgverlener: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Farmaceutisch product
 
|style="background-color: white;"|Zie [[#d4e169|Farmaceutisch product: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|style="background-color: white;"|Vanaf T - 21 dagen, 1 maal per dag 1 stuk, Oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|style="background-color: white;"|1 maal per dag 1 stuk
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Toelichting
 
|style="background-color: white;"|In overleg met specialist
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|style="background-color: white;"|MBH_920_toelichting-VNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset2-2-2 /><section end=mg-mgr-mg-MA-Scenarioset2-2-2 />
 
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 2==
 
<section begin=mg-mgr-mg-MA-Scenarioset2-2-3 /><section begin=patient-mg-mgr-mg-MA-Scenarioset2-2-3 />
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="4" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="5"|Naamgegevens
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="6"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Initialen
 
|style="background-color: white;"|C.
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Geslachtsnaam
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Achternaam
 
|style="background-color: white;"|XXX_Vonker
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Identificatienummer
 
|style="background-color: white;"|999910401 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geboortedatum
 
|style="background-color: white;"|8 feb 1954
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
 
|}<section end=patient-mg-mgr-mg-MA-Scenarioset2-2-3 /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset2-2-3 />
 
==== Scenario 2.3 - MBH_920_redenvanvoorschrijven-VNK====
 
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_redenvanvoorschrijven_MA-VNK
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="3" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|style="background-color: white;"|MBH_920_redenvanvoorschrijven_MA-VNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Medicatieafspraak datum tijd
 
|style="background-color: white;"|T - 13 dagen om 08:05 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="3"|Gebruiksperiode
 
|style="background-color: #E3E3E3;;"|''Vanaf T - 13 dagen, tot en met T + 14 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|style="background-color: white;"|T - 13 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Einddatum
 
|style="background-color: white;"|T + 14 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Voorschrijver
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgverlener
 
|style="background-color: white;"|Zie [[#d4e279|Zorgverlener: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Reden van voorschrijven
 
|style="background-color: white;"|overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Reumatoide artritis
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Farmaceutisch product
 
|style="background-color: white;"|Zie [[#d4e301|Farmaceutisch product: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|style="background-color: white;"|Vanaf T - 13 dagen, tot en met T + 14 dagen, 1 maal per week 5 stuks, Oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|style="background-color: white;"|1 maal per week 5 stuks
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|style="background-color: white;"|MBH_920_redenvanvoorschrijven-VNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset2-2-3 /><section end=mg-mgr-mg-MA-Scenarioset2-2-3 />
 
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 2==
 
<section begin=mg-mgr-mg-MA-Scenarioset2-2-4 /><section begin=patient-mg-mgr-mg-MA-Scenarioset2-2-4 />
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="4" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="5"|Naamgegevens
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="6"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Initialen
 
|style="background-color: white;"|C.
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Geslachtsnaam
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Achternaam
 
|style="background-color: white;"|XXX_Vonker
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Identificatienummer
 
|style="background-color: white;"|999910401 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geboortedatum
 
|style="background-color: white;"|8 feb 1954
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
 
|}<section end=patient-mg-mgr-mg-MA-Scenarioset2-2-4 /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset2-2-4 />
 
==== Scenario 2.4 - MBH_920_aanvullendeinformatiewensen-VNK====
 
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_aanvullendeinformatiewensen_MA-VNK
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="3" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|style="background-color: white;"|MBH_920_aanvullendeinformatiewensen_MA-VNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Medicatieafspraak datum tijd
 
|style="background-color: white;"|T - 5 dagen om 08:06 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="3"|Gebruiksperiode
 
|style="background-color: #E3E3E3;;"|''Vanaf T - 4 dagen, tot en met T + 5 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|style="background-color: white;"|T - 4 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Einddatum
 
|style="background-color: white;"|T + 5 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Voorschrijver
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgverlener
 
|style="background-color: white;"|Zie [[#d4e408|Zorgverlener: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Farmaceutisch product
 
|style="background-color: white;"|Zie [[#d4e427|Farmaceutisch product: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|style="background-color: white;"|Vanaf T - 4 dagen, tot en met T + 5 dagen, 3 maal per dag 1 stuk, Oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|style="background-color: white;"|3 maal per dag 1 stuk
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Aanvullende informatie
 
|style="background-color: white;"|Bewust hoge dosering (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2050')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|style="background-color: white;"|MBH_920_aanvullendeinformatiewensen-VNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset2-2-4 /><section end=mg-mgr-mg-MA-Scenarioset2-2-4 />
 
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 2==
 
<section begin=mg-mgr-mg-MA-Scenarioset2-2-5 /><section begin=patient-mg-mgr-mg-MA-Scenarioset2-2-5 />
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="4" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="5"|Naamgegevens
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="6"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Initialen
 
|style="background-color: white;"|C.
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Geslachtsnaam
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Achternaam
 
|style="background-color: white;"|XXX_Vonker
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Identificatienummer
 
|style="background-color: white;"|999910401 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geboortedatum
 
|style="background-color: white;"|8 feb 1954
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
 
|}<section end=patient-mg-mgr-mg-MA-Scenarioset2-2-5 /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset2-2-5 />
 
==== Scenario 2.5 - MBH_920_Toedieningsweg-VNK====
 
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_Toedieningsweg_MA-VNK
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="3" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|style="background-color: white;"|MBH_920_Toedieningsweg_MA-VNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Medicatieafspraak datum tijd
 
|style="background-color: white;"|T - 5 dagen om 08:15 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="3"|Gebruiksperiode
 
|style="background-color: #E3E3E3;;"|''Vanaf T - 5 dagen, tot en met T + 2 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|style="background-color: white;"|T - 5 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Einddatum
 
|style="background-color: white;"|T + 2 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Voorschrijver
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgverlener
 
|style="background-color: white;"|Zie [[#d4e537|Zorgverlener: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Farmaceutisch product
 
|style="background-color: white;"|Zie [[#d4e556|Farmaceutisch product: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="5"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|style="background-color: white;"|Vanaf T - 5 dagen, tot en met T + 2 dagen, 2 maal per dag 1 druppel, In het rechter oog, oculair
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|style="background-color: white;"|oculair (code = '7' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Aanvullende instructie
 
|style="background-color: white;"|overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): In het rechter oog
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|style="background-color: white;"|2 maal per dag 1 druppel
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Aanvullende informatie
 
|style="background-color: white;"|Bewust afwijkende toedieningsweg (code = '3' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2050')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|style="background-color: white;"|MBH_920_Toedieningsweg-VNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset2-2-5 /><section end=mg-mgr-mg-MA-Scenarioset2-2-5 />
 
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 3 (Staken Wijzigen)==
 
<section begin=mg-mgr-mg-MA-Scenarioset3-3-1 /><section begin=patient-mg-mgr-mg-MA-Scenarioset3-3-1 />
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="4" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="5"|Naamgegevens
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="6"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Initialen
 
|style="background-color: white;"|C.
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Geslachtsnaam
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Achternaam
 
|style="background-color: white;"|XXX_Vonker
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Identificatienummer
 
|style="background-color: white;"|999910401 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geboortedatum
 
|style="background-color: white;"|8 feb 1954
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
 
|}<section end=patient-mg-mgr-mg-MA-Scenarioset3-3-1 /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset3-3-1 />
 
==== Scenario 3.1 - MBH_920_aanvullendeinstructie-VNK====
 
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_aanvullendeinstructie_MA_staken-VNK
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="3" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|style="background-color: white;"|MBH_920_aanvullendeinstructie_MA_staken-VNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Medicatieafspraak datum tijd
 
|style="background-color: white;"|T - 10 dagen om 18:00 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="3"|Gebruiksperiode
 
|style="background-color: #E3E3E3;;"|''Vanaf T - 4 maanden, tot en met T - 10 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|style="background-color: white;"|T - 4 maanden
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Einddatum
 
|style="background-color: white;"|T - 10 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Medicatieafspraak stop type
 
|style="background-color: white;"|Definitief (code = '2' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1')
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Relatie medicatieafspraak
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Identificatie
 
|style="background-color: white;"|MBH_920_aanvullendeinstructie_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Voorschrijver
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgverlener
 
|style="background-color: white;"|Zie [[#d4e26|Zorgverlener: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Reden wijzigen of staken
 
|style="background-color: white;"|Interactie (code = '79899007' in codeSystem 'SNOMED CT')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Farmaceutisch product
 
|style="background-color: white;"|Zie [[#d4e46|Farmaceutisch product: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="5"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|style="background-color: white;"|Vanaf T - 4 maanden, tot en met T - 10 dagen, 1 maal per dag 1 stuk, Bij het eten innemen, Oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Aanvullende instructie
 
|style="background-color: white;"|overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Bij het eten innemen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|style="background-color: white;"|1 maal per dag 1 stuk
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|style="background-color: white;"|MBH_920_aanvullendeinstructie-VNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset3-3-1 /><section end=mg-mgr-mg-MA-Scenarioset3-3-1 />
 
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 3 (Staken Wijzigen)==
 
<section begin=mg-mgr-mg-MA-Scenarioset3-3-2 /><section begin=patient-mg-mgr-mg-MA-Scenarioset3-3-2 />
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="4" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="5"|Naamgegevens
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="6"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Initialen
 
|style="background-color: white;"|C.
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Geslachtsnaam
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Achternaam
 
|style="background-color: white;"|XXX_Vonker
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Identificatienummer
 
|style="background-color: white;"|999910401 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geboortedatum
 
|style="background-color: white;"|8 feb 1954
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
 
|}<section end=patient-mg-mgr-mg-MA-Scenarioset3-3-2 /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset3-3-2 />
 
==== Scenario 3.2 - MBH_920_toelichting-VNK====
 
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_toelichting_MA_wijzigingmetVV-VNK
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="3" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|style="background-color: white;"|MBH_920_toelichting_MA_wijzigingmetVV-VNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Medicatieafspraak datum tijd
 
|style="background-color: white;"|T - 2 dagen om 08:02 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="3"|Gebruiksperiode
 
|style="background-color: #E3E3E3;;"|''Vanaf T - 2 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|style="background-color: white;"|T - 2 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Relatie medicatieafspraak
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Identificatie
 
|style="background-color: white;"|MBH_920_toelichting_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Voorschrijver
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgverlener
 
|style="background-color: white;"|Zie [[#d4e105|Zorgverlener: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Reden wijzigen of staken
 
|style="background-color: white;"|Geen of onvoldoende effect (code = '5' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Farmaceutisch product
 
|style="background-color: white;"|Zie [[#d4e125|Farmaceutisch product: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|style="background-color: white;"|Vanaf T - 2 dagen, 1 maal per dag 2 stuks, Oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|style="background-color: white;"|1 maal per dag 2 stuks
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|style="background-color: white;"|MBH_920_toelichting-VNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_toelichting_MA_techstaken-VNK
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="3" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|style="background-color: white;"|MBH_920_toelichting_MA_techstaken-VNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Medicatieafspraak datum tijd
 
|style="background-color: white;"|T - 2 dagen om 08:02 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="3"|Gebruiksperiode
 
|style="background-color: #E3E3E3;;"|''Vanaf T - 21 dagen, tot en met T - 3 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|style="background-color: white;"|T - 21 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Einddatum
 
|style="background-color: white;"|T - 3 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Medicatieafspraak stop type
 
|style="background-color: white;"|Definitief (code = '2' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1')
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Relatie medicatieafspraak
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Identificatie
 
|style="background-color: white;"|MBH_920_toelichting_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Voorschrijver
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgverlener
 
|style="background-color: white;"|Zie [[#d4e151|Zorgverlener: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Farmaceutisch product
 
|style="background-color: white;"|Zie [[#d4e170|Farmaceutisch product: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|style="background-color: white;"|Vanaf T - 21 dagen, tot en met T - 3 dagen, 1 maal per dag 1 stuk, Oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|style="background-color: white;"|1 maal per dag 1 stuk
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|style="background-color: white;"|MBH_920_toelichting-VNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset3-3-2 /><section end=mg-mgr-mg-MA-Scenarioset3-3-2 />
 
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 3 (Staken Wijzigen)==
 
<section begin=mg-mgr-mg-MA-Scenarioset3-3-3 /><section begin=patient-mg-mgr-mg-MA-Scenarioset3-3-3 />
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="4" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="5"|Naamgegevens
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="6"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Initialen
 
|style="background-color: white;"|C.
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Geslachtsnaam
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Achternaam
 
|style="background-color: white;"|XXX_Vonker
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Identificatienummer
 
|style="background-color: white;"|999910401 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geboortedatum
 
|style="background-color: white;"|8 feb 1954
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
 
|}<section end=patient-mg-mgr-mg-MA-Scenarioset3-3-3 /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset3-3-3 />
 
==== Scenario 3.3 - MBH_920_redenvanvoorschrijven-VNK====
 
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_redenvanvoorschrijven_MA_wijzigingzonderVV-VNK
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="3" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|style="background-color: white;"|MBH_920_redenvanvoorschrijven_MA_wijzigingzonderVV-VNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Medicatieafspraak datum tijd
 
|style="background-color: white;"|T - 1 dag om 08:10 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="3"|Gebruiksperiode
 
|style="background-color: #E3E3E3;;"|''Vanaf T - 1 dag, tot en met T + 14 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|style="background-color: white;"|T - 1 dag
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Einddatum
 
|style="background-color: white;"|T + 14 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Voorschrijver
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgverlener
 
|style="background-color: white;"|Zie [[#d4e306|Zorgverlener: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Reden wijzigen of staken
 
|style="background-color: white;"|Te sterk effect (code = '6' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Reden van voorschrijven
 
|style="background-color: white;"|overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Reumatoide artritis
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Farmaceutisch product
 
|style="background-color: white;"|Zie [[#d4e329|Farmaceutisch product: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|style="background-color: white;"|Vanaf T - 1 dag, tot en met T + 14 dagen, 1 maal per week 4 stuks, Oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|style="background-color: white;"|1 maal per week 4 stuks
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|style="background-color: white;"|MBH_920_redenvanvoorschrijven-VNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_redenvanvoorschrijven_MA_techstaken-VNK
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="3" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|style="background-color: white;"|MBH_920_redenvanvoorschrijven_MA_techstaken-VNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Medicatieafspraak datum tijd
 
|style="background-color: white;"|T - 1 dag om 08:10 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="3"|Gebruiksperiode
 
|style="background-color: #E3E3E3;;"|''Vanaf T - 13 dagen, tot en met T - 2 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|style="background-color: white;"|T - 13 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Einddatum
 
|style="background-color: white;"|T - 2 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Medicatieafspraak stop type
 
|style="background-color: white;"|Definitief (code = '2' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1')
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Relatie medicatieafspraak
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Identificatie
 
|style="background-color: white;"|MBH_920_redenvanvoorschrijven_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Voorschrijver
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgverlener
 
|style="background-color: white;"|Zie [[#d4e355|Zorgverlener: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Reden van voorschrijven
 
|style="background-color: white;"|overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Reumatoide artritis
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Farmaceutisch product
 
|style="background-color: white;"|Zie [[#d4e377|Farmaceutisch product: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|style="background-color: white;"|Vanaf T - 13 dagen, tot en met T - 2 dagen, 1 maal per week 5 stuks, Oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|style="background-color: white;"|1 maal per week 5 stuks
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|style="background-color: white;"|MBH_920_redenvanvoorschrijven-VNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset3-3-3 /><section end=mg-mgr-mg-MA-Scenarioset3-3-3 />
 
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 3 (Staken Wijzigen)==
 
<section begin=mg-mgr-mg-MA-Scenarioset3-3-4optioneel /><section begin=patient-mg-mgr-mg-MA-Scenarioset3-3-4optioneel />
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="4" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="5"|Naamgegevens
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="6"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Initialen
 
|style="background-color: white;"|C.
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Geslachtsnaam
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Achternaam
 
|style="background-color: white;"|XXX_Vonker
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Identificatienummer
 
|style="background-color: white;"|999910401 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geboortedatum
 
|style="background-color: white;"|8 feb 1954
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
 
|}<section end=patient-mg-mgr-mg-MA-Scenarioset3-3-4optioneel /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset3-3-4optioneel />
 
==== Scenario 3.4 - MBH_920_aanvullendeinformatiewensen-VNK====
 
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_aanvullendeinformatiewensen_MA_onderbreken-VNK
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="3" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|style="background-color: white;"|MBH_920_aanvullendeinformatiewensen_MA_onderbreken-VNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Medicatieafspraak datum tijd
 
|style="background-color: white;"|T - 1 dag om 18:12 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="3"|Gebruiksperiode
 
|style="background-color: #E3E3E3;;"|''Vanaf T - 4 dagen, tot en met T - 1 dag''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|style="background-color: white;"|T - 4 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Einddatum
 
|style="background-color: white;"|T - 1 dag
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Medicatieafspraak stop type
 
|style="background-color: white;"|Tijdelijk (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1')
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Relatie medicatieafspraak
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Identificatie
 
|style="background-color: white;"|MBH_920_aanvullendeinformatiewensen_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Voorschrijver
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgverlener
 
|style="background-color: white;"|Zie [[#d4e465|Zorgverlener: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Reden wijzigen of staken
 
|style="background-color: white;"|Opname (code = '305335007' in codeSystem 'SNOMED CT')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Farmaceutisch product
 
|style="background-color: white;"|Zie [[#d4e485|Farmaceutisch product: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|style="background-color: white;"|Vanaf T - 4 dagen, tot en met T - 1 dag, 3 maal per dag 1 stuk, Oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|style="background-color: white;"|3 maal per dag 1 stuk
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Aanvullende informatie
 
|style="background-color: white;"|Bewust hoge dosering (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2050')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|style="background-color: white;"|MBH_920_aanvullendeinformatiewensen-VNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset3-3-4optioneel /><section end=mg-mgr-mg-MA-Scenarioset3-3-4optioneel />
 
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 4 (Lengte/Gewicht)==
 
<section begin=mg-mgr-mg-MA-Scenarioset4-4-1 /><section begin=patient-mg-mgr-mg-MA-Scenarioset4-4-1 />
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="4" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="5"|Naamgegevens
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="6"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Initialen
 
|style="background-color: white;"|A.
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Geslachtsnaam
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Achternaam
 
|style="background-color: white;"|XXX_Molenaars
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Identificatienummer
 
|style="background-color: white;"|999910449 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geboortedatum
 
|style="background-color: white;"|8 jun 1954
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
 
|}<section end=patient-mg-mgr-mg-MA-Scenarioset4-4-1 /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset4-4-1 />
 
==== Scenario 4.1 - MBH_920_Lengte_Gewicht-MLN====
 
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_Lengte_Gewicht_MA_1-MLN
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="3" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|style="background-color: white;"|MBH_920_Lengte_Gewicht_MA_1-MLN (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Medicatieafspraak datum tijd
 
|style="background-color: white;"|T - 1 jaar om 07:05 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="3"|Gebruiksperiode
 
|style="background-color: #E3E3E3;;"|''Vanaf T - 1 jaar''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|style="background-color: white;"|T - 1 jaar
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Voorschrijver
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgverlener
 
|style="background-color: white;"|Zie [[#d4e22|Zorgverlener: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Farmaceutisch product
 
|style="background-color: white;"|Zie [[#d4e41|Farmaceutisch product: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|style="background-color: white;"|Vanaf T - 1 jaar, 1 maal per dag 1 stuk, Oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|style="background-color: white;"|1 maal per dag 1 stuk
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|style="background-color: white;"|MBH_920_Lengte_Gewicht-MLN (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset4-4-1 /><section end=mg-mgr-mg-MA-Scenarioset4-4-1 />
 
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 6 (Doseerschemas)==
 
<section begin=mg-mgr-mg-MA-Scenarioset6-6-1optioneel /><section begin=patient-mg-mgr-mg-MA-Scenarioset6-6-1optioneel />
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="4" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="5"|Naamgegevens
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="6"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Initialen
 
|style="background-color: white;"|N.
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Geslachtsnaam
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Achternaam
 
|style="background-color: white;"|XXX_Maasz
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Identificatienummer
 
|style="background-color: white;"|999910747 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geboortedatum
 
|style="background-color: white;"|10 aug 1954
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
 
|}<section end=patient-mg-mgr-mg-MA-Scenarioset6-6-1optioneel /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset6-6-1optioneel />
 
==== Scenario 6.1 - MBH_920_variabelefrequentie-MSZ====
 
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_variabelefrequentie_MA-MSZ
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="3" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|style="background-color: white;"|MBH_920_variabelefrequentie_MA-MSZ (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Medicatieafspraak datum tijd
 
|style="background-color: white;"|T om 08:00 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="3"|Gebruiksperiode
 
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 16 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|style="background-color: white;"|T
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Einddatum
 
|style="background-color: white;"|T + 16 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Voorschrijver
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgverlener
 
|style="background-color: white;"|Zie [[#d4e23|Zorgverlener: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Farmaceutisch product
 
|style="background-color: white;"|Zie [[#d4e42|Farmaceutisch product: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|style="background-color: white;"|Vanaf T, tot en met T + 16 dagen, maal per dag 1 stuk, Oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|style="background-color: white;"|maal per dag 1 stuk
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|style="background-color: white;"|MBH_920_variabelefrequentie-MSZ (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset6-6-1optioneel /><section end=mg-mgr-mg-MA-Scenarioset6-6-1optioneel />
 
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 6 (Doseerschemas)==
 
<section begin=mg-mgr-mg-MA-Scenarioset6-6-2optioneel /><section begin=patient-mg-mgr-mg-MA-Scenarioset6-6-2optioneel />
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="4" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="5"|Naamgegevens
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="6"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Initialen
 
|style="background-color: white;"|N.
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Geslachtsnaam
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Achternaam
 
|style="background-color: white;"|XXX_Maasz
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Identificatienummer
 
|style="background-color: white;"|999910747 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geboortedatum
 
|style="background-color: white;"|10 aug 1954
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
 
|}<section end=patient-mg-mgr-mg-MA-Scenarioset6-6-2optioneel /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset6-6-2optioneel />
 
==== Scenario 6.2 - MBH_920_interval-MSZ====
 
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_interval_MA-MSZ
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="3" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|style="background-color: white;"|MBH_920_interval_MA-MSZ (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Medicatieafspraak datum tijd
 
|style="background-color: white;"|T om 08:04 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="3"|Gebruiksperiode
 
|style="background-color: #E3E3E3;;"|''Vanaf T''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|style="background-color: white;"|T
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Voorschrijver
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgverlener
 
|style="background-color: white;"|Zie [[#d4e150|Zorgverlener: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Farmaceutisch product
 
|style="background-color: white;"|Zie [[#d4e169|Farmaceutisch product: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|style="background-color: white;"|Vanaf T, exact iedere 8 uur 1 stuk, Oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|style="background-color: white;"|exact iedere 8 uur 1 stuk
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|style="background-color: white;"|MBH_920_interval-MSZ (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset6-6-2optioneel /><section end=mg-mgr-mg-MA-Scenarioset6-6-2optioneel />
 
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 6 (Doseerschemas)==
 
<section begin=mg-mgr-mg-MA-Scenarioset6-6-3optioneel /><section begin=patient-mg-mgr-mg-MA-Scenarioset6-6-3optioneel />
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="4" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="5"|Naamgegevens
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="6"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Initialen
 
|style="background-color: white;"|N.
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Geslachtsnaam
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Achternaam
 
|style="background-color: white;"|XXX_Maasz
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Identificatienummer
 
|style="background-color: white;"|999910747 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geboortedatum
 
|style="background-color: white;"|10 aug 1954
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
 
|}<section end=patient-mg-mgr-mg-MA-Scenarioset6-6-3optioneel /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset6-6-3optioneel />
 
==== Scenario 6.3 - MBH_920_variabelehoeveelheid-MSZ====
 
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_variabelehoeveelheid_MA-MSZ
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="3" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|style="background-color: white;"|MBH_920_variabelehoeveelheid_MA-MSZ (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Medicatieafspraak datum tijd
 
|style="background-color: white;"|T om 08:10 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="3"|Gebruiksperiode
 
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 28 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|style="background-color: white;"|T
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Einddatum
 
|style="background-color: white;"|T + 28 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Voorschrijver
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgverlener
 
|style="background-color: white;"|Zie [[#d4e269|Zorgverlener: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Farmaceutisch product
 
|style="background-color: white;"|Zie [[#d4e288|Farmaceutisch product: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|style="background-color: white;"|Vanaf T, tot en met T + 28 dagen, 3 maal per dag stuks, oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|style="background-color: white;"|3 maal per dag stuks
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|style="background-color: white;"|MBH_920_variabelehoeveelheid-MSZ (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset6-6-3optioneel /><section end=mg-mgr-mg-MA-Scenarioset6-6-3optioneel />
 
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 6 (Doseerschemas)==
 
<section begin=mg-mgr-mg-MA-Scenarioset6-6-4optioneel /><section begin=patient-mg-mgr-mg-MA-Scenarioset6-6-4optioneel />
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="4" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="5"|Naamgegevens
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="6"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Initialen
 
|style="background-color: white;"|N.
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Geslachtsnaam
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Achternaam
 
|style="background-color: white;"|XXX_Maasz
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Identificatienummer
 
|style="background-color: white;"|999910747 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geboortedatum
 
|style="background-color: white;"|10 aug 1954
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
 
|}<section end=patient-mg-mgr-mg-MA-Scenarioset6-6-4optioneel /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset6-6-4optioneel />
 
==== Scenario 6.4 - MBH_920_zonderkeerdosis-MSZ====
 
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_zonderkeerdosis_MA-MSZ
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="3" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|style="background-color: white;"|MBH_920_zonderkeerdosis_MA-MSZ (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Medicatieafspraak datum tijd
 
|style="background-color: white;"|T om 08:12 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="3"|Gebruiksperiode
 
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 28 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|style="background-color: white;"|T
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Einddatum
 
|style="background-color: white;"|T + 28 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Voorschrijver
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgverlener
 
|style="background-color: white;"|Zie [[#d4e397|Zorgverlener: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Farmaceutisch product
 
|style="background-color: white;"|Zie [[#d4e416|Farmaceutisch product: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="5"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|style="background-color: white;"|Vanaf T, tot en met T + 28 dagen, 3 maal per dag, aanbrengen, cutaan
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Aanvullende instructie
 
|style="background-color: white;"|aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|style="background-color: white;"|3 maal per dag
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|style="background-color: white;"|MBH_920_zonderkeerdosis-MSZ (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset6-6-4optioneel /><section end=mg-mgr-mg-MA-Scenarioset6-6-4optioneel />
 
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 6 (Doseerschemas)==
 
<section begin=mg-mgr-mg-MA-Scenarioset6-6-5optioneel /><section begin=patient-mg-mgr-mg-MA-Scenarioset6-6-5optioneel />
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="4" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="5"|Naamgegevens
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="6"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Initialen
 
|style="background-color: white;"|N.
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Geslachtsnaam
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Achternaam
 
|style="background-color: white;"|XXX_Maasz
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Identificatienummer
 
|style="background-color: white;"|999910747 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geboortedatum
 
|style="background-color: white;"|10 aug 1954
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
 
|}<section end=patient-mg-mgr-mg-MA-Scenarioset6-6-5optioneel /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset6-6-5optioneel />
 
==== Scenario 6.5 - MBH_920_bijzonderekeerdosis-MSZ====
 
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_bijzonderekeerdosis_MA-MSZ
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="3" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|style="background-color: white;"|MBH_920_bijzonderekeerdosis_MA-MSZ (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Medicatieafspraak datum tijd
 
|style="background-color: white;"|T om 08:15 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="3"|Gebruiksperiode
 
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 28 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|style="background-color: white;"|T
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Einddatum
 
|style="background-color: white;"|T + 28 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Voorschrijver
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgverlener
 
|style="background-color: white;"|Zie [[#d4e517|Zorgverlener: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Farmaceutisch product
 
|style="background-color: white;"|Zie [[#d4e536|Farmaceutisch product: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|style="background-color: white;"|Vanaf T, tot en met T + 28 dagen, 2 maal per dag 0.5 stuk, oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|style="background-color: white;"|2 maal per dag 0.5 stuk
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|style="background-color: white;"|MBH_920_bijzonderekeerdosis-MSZ (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset6-6-5optioneel /><section end=mg-mgr-mg-MA-Scenarioset6-6-5optioneel />
 
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 6 (Doseerschemas)==
 
<section begin=mg-mgr-mg-MA-Scenarioset6-6-6optioneel /><section begin=patient-mg-mgr-mg-MA-Scenarioset6-6-6optioneel />
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="4" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="5"|Naamgegevens
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="6"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Initialen
 
|style="background-color: white;"|N.
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Geslachtsnaam
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Achternaam
 
|style="background-color: white;"|XXX_Maasz
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Identificatienummer
 
|style="background-color: white;"|999910747 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geboortedatum
 
|style="background-color: white;"|10 aug 1954
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
 
|}<section end=patient-mg-mgr-mg-MA-Scenarioset6-6-6optioneel /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset6-6-6optioneel />
 
==== Scenario 6.6 - MBH_920_variabelehoeveelheid2-MSZ====
 
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_variabelehoeveelheid2_MA-MSZ
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="3" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|style="background-color: white;"|MBH_920_variabelehoeveelheid2_MA-MSZ (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Medicatieafspraak datum tijd
 
|style="background-color: white;"|T om 08:18 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="3"|Gebruiksperiode
 
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 28 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|style="background-color: white;"|T
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Einddatum
 
|style="background-color: white;"|T + 28 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Voorschrijver
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgverlener
 
|style="background-color: white;"|Zie [[#d4e643|Zorgverlener: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Farmaceutisch product
 
|style="background-color: white;"|Zie [[#d4e662|Farmaceutisch product: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="6"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|style="background-color: white;"|Vanaf T, tot en met T + 28 dagen, 2 maal per dag ml, Eerst oplossen in water, mond spoelen, daarna uitspugen, OROMUCOSAAL
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|style="background-color: white;"|OROMUCOSAAL (code = '34' in codeSystem 'G-Standaard Toedieningswegen')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Aanvullende instructie
 
|style="background-color: white;"|Eerst oplossen in water (code = '27' in codeSystem 'NHG tabel 25 aanvullende tekst')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Aanvullende instructie
 
|style="background-color: white;"|mond spoelen, daarna uitspugen (code = '69' in codeSystem 'NHG tabel 25 aanvullende tekst')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|style="background-color: white;"|2 maal per dag ml
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|style="background-color: white;"|MBH_920_variabelehoeveelheid2-MSZ (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset6-6-6optioneel /><section end=mg-mgr-mg-MA-Scenarioset6-6-6optioneel />
 
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 6 (Doseerschemas)==
 
<section begin=mg-mgr-mg-MA-Scenarioset6-6-7 /><section begin=patient-mg-mgr-mg-MA-Scenarioset6-6-7 />
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="4" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="5"|Naamgegevens
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="6"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Initialen
 
|style="background-color: white;"|N.
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Geslachtsnaam
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Achternaam
 
|style="background-color: white;"|XXX_Maasz
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Identificatienummer
 
|style="background-color: white;"|999910747 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geboortedatum
 
|style="background-color: white;"|10 aug 1954
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
 
|}<section end=patient-mg-mgr-mg-MA-Scenarioset6-6-7 /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset6-6-7 />
 
==== Scenario 6.7 - MBH_920_tijdstippen-MSZ====
 
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_tijdstippen_MA-MSZ
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="3" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|style="background-color: white;"|MBH_920_tijdstippen_MA-MSZ (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Medicatieafspraak datum tijd
 
|style="background-color: white;"|T om 08:24 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="3"|Gebruiksperiode
 
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 14 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|style="background-color: white;"|T
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Einddatum
 
|style="background-color: white;"|T + 14 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Voorschrijver
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgverlener
 
|style="background-color: white;"|Zie [[#d4e775|Zorgverlener: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Farmaceutisch product
 
|style="background-color: white;"|Zie [[#d4e794|Farmaceutisch product: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|style="background-color: white;"|Vanaf T, tot en met T + 14 dagen, elke dag om 08:00:00, 14:00:00 en 20:00:00 1 stuk, oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|style="background-color: white;"|elke dag om 08:00:00, 14:00:00 en 20:00:00 1 stuk
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|style="background-color: white;"|MBH_920_tijdstippen-MSZ (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset6-6-7 /><section end=mg-mgr-mg-MA-Scenarioset6-6-7 />
 
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 6 (Doseerschemas)==
 
<section begin=mg-mgr-mg-MA-Scenarioset6-6-8optioneel /><section begin=patient-mg-mgr-mg-MA-Scenarioset6-6-8optioneel />
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="4" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="5"|Naamgegevens
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="6"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Initialen
 
|style="background-color: white;"|N.
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Geslachtsnaam
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Achternaam
 
|style="background-color: white;"|XXX_Maasz
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Identificatienummer
 
|style="background-color: white;"|999910747 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geboortedatum
 
|style="background-color: white;"|10 aug 1954
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
 
|}<section end=patient-mg-mgr-mg-MA-Scenarioset6-6-8optioneel /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset6-6-8optioneel />
 
==== Scenario 6.8 - MBH_920_weekdagen-MSZ====
 
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_weekdagen_MA-MSZ
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="3" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|style="background-color: white;"|MBH_920_weekdagen_MA-MSZ (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Medicatieafspraak datum tijd
 
|style="background-color: white;"|T om 08:25 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="3"|Gebruiksperiode
 
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 70 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|style="background-color: white;"|T
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Einddatum
 
|style="background-color: white;"|T + 70 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Voorschrijver
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgverlener
 
|style="background-color: white;"|Zie [[#d4e899|Zorgverlener: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Farmaceutisch product
 
|style="background-color: white;"|Zie [[#d4e918|Farmaceutisch product: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="6"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|style="background-color: white;"|Vanaf T, tot en met T + 70 dagen, op maandag, woensdag en vrijdag, voor de nacht, aanbrengen, cutaan
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Aanvullende instructie
 
|style="background-color: white;"|voor de nacht (code = '1128' in codeSystem 'NHG tabel 25 aanvullende tekst')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Aanvullende instructie
 
|style="background-color: white;"|aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|style="background-color: white;"|op maandag, woensdag en vrijdag
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|style="background-color: white;"|MBH_920_weekdagen-MSZ (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset6-6-8optioneel /><section end=mg-mgr-mg-MA-Scenarioset6-6-8optioneel />
 
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 6 (Doseerschemas)==
 
<section begin=mg-mgr-mg-MA-Scenarioset6-6-9 /><section begin=patient-mg-mgr-mg-MA-Scenarioset6-6-9 />
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="4" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="5"|Naamgegevens
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="6"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Initialen
 
|style="background-color: white;"|N.
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Geslachtsnaam
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Achternaam
 
|style="background-color: white;"|XXX_Maasz
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Identificatienummer
 
|style="background-color: white;"|999910747 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geboortedatum
 
|style="background-color: white;"|10 aug 1954
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
 
|}<section end=patient-mg-mgr-mg-MA-Scenarioset6-6-9 /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset6-6-9 />
 
==== Scenario 6.9 - MBH_920_dagdeel-MSZ====
 
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_dagdeel_MA-MSZ
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="3" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|style="background-color: white;"|MBH_920_dagdeel_MA-MSZ (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Medicatieafspraak datum tijd
 
|style="background-color: white;"|T om 08:27 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="3"|Gebruiksperiode
 
|style="background-color: #E3E3E3;;"|''Vanaf T''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|style="background-color: white;"|T
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Voorschrijver
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgverlener
 
|style="background-color: white;"|Zie [[#d4e1018|Zorgverlener: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Farmaceutisch product
 
|style="background-color: white;"|Zie [[#d4e1037|Farmaceutisch product: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|style="background-color: white;"|Vanaf T, 1 stuk 's avonds, oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|style="background-color: white;"|1 stuk 's avonds
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|style="background-color: white;"|MBH_920_dagdeel-MSZ (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset6-6-9 /><section end=mg-mgr-mg-MA-Scenarioset6-6-9 />
 
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 6 (Doseerschemas)==
 
<section begin=mg-mgr-mg-MA-Scenarioset6-6-10optioneel /><section begin=patient-mg-mgr-mg-MA-Scenarioset6-6-10optioneel />
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="4" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="5"|Naamgegevens
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="6"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Initialen
 
|style="background-color: white;"|N.
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Geslachtsnaam
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Achternaam
 
|style="background-color: white;"|XXX_Maasz
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Identificatienummer
 
|style="background-color: white;"|999910747 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geboortedatum
 
|style="background-color: white;"|10 aug 1954
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
 
|}<section end=patient-mg-mgr-mg-MA-Scenarioset6-6-10optioneel /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset6-6-10optioneel />
 
==== Scenario 6.10 - MBH_920_cyclischschema-MSZ====
 
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_cyclischschema_MA-MSZ
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="3" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|style="background-color: white;"|MBH_920_cyclischschema_MA-MSZ (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Medicatieafspraak datum tijd
 
|style="background-color: white;"|T om 08:33 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="3"|Gebruiksperiode
 
|style="background-color: #E3E3E3;;"|''Vanaf T''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|style="background-color: white;"|T
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Voorschrijver
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgverlener
 
|style="background-color: white;"|Zie [[#d4e1136|Zorgverlener: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Farmaceutisch product
 
|style="background-color: white;"|Zie [[#d4e1155|Farmaceutisch product: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="5"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|style="background-color: white;"|Vanaf T, cyclus van 28 dagen: steeds gedurende 21 dagen 1 maal per dag 1 stuk, oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|style="background-color: white;"|gedurende 21 dagen 1 maal per dag 1 stuk
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Herhaalperiode cyclisch schema
 
|style="background-color: white;"|28 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|style="background-color: white;"|MBH_920_cyclischschema-MSZ (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset6-6-10optioneel /><section end=mg-mgr-mg-MA-Scenarioset6-6-10optioneel />
 
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 6 (Doseerschemas)==
 
<section begin=mg-mgr-mg-MA-Scenarioset6-6-11optioneel /><section begin=patient-mg-mgr-mg-MA-Scenarioset6-6-11optioneel />
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="4" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="5"|Naamgegevens
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="6"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Initialen
 
|style="background-color: white;"|N.
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Geslachtsnaam
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Achternaam
 
|style="background-color: white;"|XXX_Maasz
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Identificatienummer
 
|style="background-color: white;"|999910747 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geboortedatum
 
|style="background-color: white;"|10 aug 1954
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
 
|}<section end=patient-mg-mgr-mg-MA-Scenarioset6-6-11optioneel /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset6-6-11optioneel />
 
==== Scenario 6.11 - MBH_920_afbouwschema-MSZ====
 
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_afbouwschema_MA-MSZ
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="3" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|style="background-color: white;"|MBH_920_afbouwschema_MA-MSZ (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Medicatieafspraak datum tijd
 
|style="background-color: white;"|T om 08:40 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="3"|Gebruiksperiode
 
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 41 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|style="background-color: white;"|T
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Einddatum
 
|style="background-color: white;"|T + 41 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Voorschrijver
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgverlener
 
|style="background-color: white;"|Zie [[#d4e1266|Zorgverlener: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Farmaceutisch product
 
|style="background-color: white;"|Zie [[#d4e1285|Farmaceutisch product: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="6"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|style="background-color: white;"|Vanaf T, tot en met T + 41 dagen, eerst gedurende 2 weken 1 maal per dag 3 gram, dan gedurende 3 weken 1 maal per dag 2 gram, dan gedurende 6 dagen 1 maal per dag 1 gram, cutaan
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie 1
 
|style="background-color: white;"|eerst gedurende 2 weken 1 maal per dag 3 gram
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie 2
 
|style="background-color: white;"|dan gedurende 3 weken 1 maal per dag 2 gram
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie 3
 
|style="background-color: white;"|dan gedurende 6 dagen 1 maal per dag 1 gram
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|style="background-color: white;"|MBH_920_afbouwschema-MSZ (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset6-6-11optioneel /><section end=mg-mgr-mg-MA-Scenarioset6-6-11optioneel />
 
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 6 (Doseerschemas)==
 
<section begin=mg-mgr-mg-MA-Scenarioset6-6-12optioneel /><section begin=patient-mg-mgr-mg-MA-Scenarioset6-6-12optioneel />
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="4" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="5"|Naamgegevens
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="6"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Initialen
 
|style="background-color: white;"|N.
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Geslachtsnaam
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Achternaam
 
|style="background-color: white;"|XXX_Maasz
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Identificatienummer
 
|style="background-color: white;"|999910747 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geboortedatum
 
|style="background-color: white;"|10 aug 1954
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
 
|}<section end=patient-mg-mgr-mg-MA-Scenarioset6-6-12optioneel /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset6-6-12optioneel />
 
==== Scenario 6.12 - MBH_920_variabelehoeveelheidenmaximum-MSZ====
 
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_variabelehoeveelheidenmaximum_MA-MSZ
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="3" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|style="background-color: white;"|MBH_920_variabelehoeveelheidenmaximum_MA-MSZ (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Medicatieafspraak datum tijd
 
|style="background-color: white;"|T om 08:45 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="3"|Gebruiksperiode
 
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 21 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|style="background-color: white;"|T
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Einddatum
 
|style="background-color: white;"|T + 21 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Voorschrijver
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgverlener
 
|style="background-color: white;"|Zie [[#d4e1448|Zorgverlener: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Farmaceutisch product
 
|style="background-color: white;"|Zie [[#d4e1467|Farmaceutisch product: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|style="background-color: white;"|Vanaf T, tot en met T + 21 dagen, bij hoest stuks , maximaal 6 stuks per dag, oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|style="background-color: white;"|bij hoest stuks , maximaal 6 stuks per dag
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|style="background-color: white;"|MBH_920_variabelehoeveelheidenmaximum-MSZ (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset6-6-12optioneel /><section end=mg-mgr-mg-MA-Scenarioset6-6-12optioneel />
 
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 6 (Doseerschemas)==
 
<section begin=mg-mgr-mg-MA-Scenarioset6-6-13optioneel /><section begin=patient-mg-mgr-mg-MA-Scenarioset6-6-13optioneel />
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="4" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="5"|Naamgegevens
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="6"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Initialen
 
|style="background-color: white;"|N.
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Geslachtsnaam
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Achternaam
 
|style="background-color: white;"|XXX_Maasz
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Identificatienummer
 
|style="background-color: white;"|999910747 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geboortedatum
 
|style="background-color: white;"|10 aug 1954
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
 
|}<section end=patient-mg-mgr-mg-MA-Scenarioset6-6-13optioneel /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset6-6-13optioneel />
 
==== Scenario 6.13 - MBH_920_toedieningssnelheid-MSZ====
 
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_toedieningssnelheid_MA-MSZ
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="3" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|style="background-color: white;"|MBH_920_toedieningssnelheid_MA-MSZ (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Medicatieafspraak datum tijd
 
|style="background-color: white;"|T om 08:47 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="3"|Gebruiksperiode
 
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 8 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|style="background-color: white;"|T
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Einddatum
 
|style="background-color: white;"|T + 8 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Voorschrijver
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgverlener
 
|style="background-color: white;"|Zie [[#d4e1580|Zorgverlener: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Farmaceutisch product
 
|style="background-color: white;"|Zie [[#d4e1599|Farmaceutisch product: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|style="background-color: white;"|Vanaf T, tot en met T + 8 dagen, toedieningssnelheid: ml per uur, parenteraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|style="background-color: white;"|parenteraal (code = '10' in codeSystem 'G-Standaard Toedieningswegen')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|style="background-color: white;"|toedieningssnelheid: ml per uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|style="background-color: white;"|MBH_920_toedieningssnelheid-MSZ (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset6-6-13optioneel /><section end=mg-mgr-mg-MA-Scenarioset6-6-13optioneel />
 
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 6 (Doseerschemas)==
 
<section begin=mg-mgr-mg-MA-Scenarioset6-6-14optioneel /><section begin=patient-mg-mgr-mg-MA-Scenarioset6-6-14optioneel />
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="4" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="5"|Naamgegevens
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="6"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Initialen
 
|style="background-color: white;"|N.
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Geslachtsnaam
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Achternaam
 
|style="background-color: white;"|XXX_Maasz
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Identificatienummer
 
|style="background-color: white;"|999910747 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geboortedatum
 
|style="background-color: white;"|10 aug 1954
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
 
|}<section end=patient-mg-mgr-mg-MA-Scenarioset6-6-14optioneel /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset6-6-14optioneel />
 
==== Scenario 6.14 - MBH_920_toedieningsduur-MSZ====
 
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_toedieningsduur_MA-MSZ
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="3" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|style="background-color: white;"|MBH_920_toedieningsduur_MA-MSZ (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Medicatieafspraak datum tijd
 
|style="background-color: white;"|T om 08:49 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="3"|Gebruiksperiode
 
|style="background-color: #E3E3E3;;"|''Vanaf T''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|style="background-color: white;"|T
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Voorschrijver
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgverlener
 
|style="background-color: white;"|Zie [[#d4e1699|Zorgverlener: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Farmaceutisch product
 
|style="background-color: white;"|Zie [[#d4e1718|Farmaceutisch product: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|style="background-color: white;"|Vanaf T, 1 maal per dag 1 stuk, transdermaal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|style="background-color: white;"|transdermaal (code = '58' in codeSystem 'G-Standaard Toedieningswegen')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|style="background-color: white;"|1 maal per dag 1 stuk
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|style="background-color: white;"|MBH_920_toedieningsduur-MSZ (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset6-6-14optioneel /><section end=mg-mgr-mg-MA-Scenarioset6-6-14optioneel />
 
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 6 (Doseerschemas)==
 
<section begin=mg-mgr-mg-MA-Scenarioset6-6-15 /><section begin=patient-mg-mgr-mg-MA-Scenarioset6-6-15 />
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="4" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="5"|Naamgegevens
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="6"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Initialen
 
|style="background-color: white;"|N.
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Geslachtsnaam
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Achternaam
 
|style="background-color: white;"|XXX_Maasz
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Identificatienummer
 
|style="background-color: white;"|999910747 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geboortedatum
 
|style="background-color: white;"|10 aug 1954
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
 
|}<section end=patient-mg-mgr-mg-MA-Scenarioset6-6-15 /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset6-6-15 />
 
==== Scenario 6.15 - MBH_920_zonodig-MSZ====
 
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_zonodig_MA-MSZ
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="3" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|style="background-color: white;"|MBH_920_zonodig_MA-MSZ (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Medicatieafspraak datum tijd
 
|style="background-color: white;"|T om 08:57 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="3"|Gebruiksperiode
 
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 27 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|style="background-color: white;"|T
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Einddatum
 
|style="background-color: white;"|T + 27 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Voorschrijver
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgverlener
 
|style="background-color: white;"|Zie [[#d4e1826|Zorgverlener: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Farmaceutisch product
 
|style="background-color: white;"|Zie [[#d4e1845|Farmaceutisch product: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|style="background-color: white;"|Vanaf T, tot en met T + 27 dagen, zo nodig 1 maal per dag 1 stuk, Oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|style="background-color: white;"|zo nodig 1 maal per dag 1 stuk
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|style="background-color: white;"|MBH_920_zonodig-MSZ (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset6-6-15 /><section end=mg-mgr-mg-MA-Scenarioset6-6-15 />
 
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 7 (Magistraal)==
 
<section begin=mg-mgr-mg-MA-Scenarioset7-7-1optioneel /><section begin=patient-mg-mgr-mg-MA-Scenarioset7-7-1optioneel />
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="4" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="5"|Naamgegevens
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="6"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Initialen
 
|style="background-color: white;"|R.
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Geslachtsnaam
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Achternaam
 
|style="background-color: white;"|XXX-TEST-E
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Identificatienummer
 
|style="background-color: white;"|999990196 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geboortedatum
 
|style="background-color: white;"|5 mei 1970
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
 
|}<section end=patient-mg-mgr-mg-MA-Scenarioset7-7-1optioneel /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset7-7-1optioneel />
 
==== Scenario 7.1 - MBH_920_magistraalalleingredienten-TST====
 
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_magistraalalleingredienten_MA-TST
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="3" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|style="background-color: white;"|MBH_920_magistraalalleingredienten_MA-TST (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Medicatieafspraak datum tijd
 
|style="background-color: white;"|T om 12:00 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="3"|Gebruiksperiode
 
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 31 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|style="background-color: white;"|T
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Einddatum
 
|style="background-color: white;"|T + 31 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Voorschrijver
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgverlener
 
|style="background-color: white;"|Zie [[#d4e23|Zorgverlener: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Farmaceutisch product
 
|style="background-color: white;"|Zie [[#d4e42|Farmaceutisch product: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|style="background-color: white;"|Vanaf T, tot en met T + 31 dagen, zo nodig, cutaan
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|style="background-color: white;"|zo nodig
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|style="background-color: white;"|MBH_920_magistraalalleingredienten-TST (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset7-7-1optioneel /><section end=mg-mgr-mg-MA-Scenarioset7-7-1optioneel />
 
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 7 (Magistraal)==
 
<section begin=mg-mgr-mg-MA-Scenarioset7-7-2optioneel /><section begin=patient-mg-mgr-mg-MA-Scenarioset7-7-2optioneel />
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="4" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="5"|Naamgegevens
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="6"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Initialen
 
|style="background-color: white;"|R.
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Geslachtsnaam
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Achternaam
 
|style="background-color: white;"|XXX-TEST-E
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Identificatienummer
 
|style="background-color: white;"|999990196 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geboortedatum
 
|style="background-color: white;"|5 mei 1970
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
 
|}<section end=patient-mg-mgr-mg-MA-Scenarioset7-7-2optioneel /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset7-7-2optioneel />
 
==== Scenario 7.2 - MBH_920_magistraalactieveingredient-TST====
 
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_magistraalactieveingredient_MA-TST
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="3" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|style="background-color: white;"|MBH_920_magistraalactieveingredient_MA-TST (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Medicatieafspraak datum tijd
 
|style="background-color: white;"|T om 12:05 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="3"|Gebruiksperiode
 
|style="background-color: #E3E3E3;;"|''Vanaf T + 1 dag, tot en met T + 70 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|style="background-color: white;"|T + 1 dag
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Einddatum
 
|style="background-color: white;"|T + 70 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Voorschrijver
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgverlener
 
|style="background-color: white;"|Zie [[#d4e215|Zorgverlener: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Farmaceutisch product
 
|style="background-color: white;"|Zie [[#d4e234|Farmaceutisch product: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|style="background-color: white;"|Vanaf T + 1 dag, tot en met T + 70 dagen, 1 maal per dag, cutaan
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|style="background-color: white;"|1 maal per dag
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|style="background-color: white;"|MBH_920_magistraalactieveingredient-TST (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset7-7-2optioneel /><section end=mg-mgr-mg-MA-Scenarioset7-7-2optioneel />
 
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 7 (Magistraal)==
 
<section begin=mg-mgr-mg-MA-Scenarioset7-7-3optioneel /><section begin=patient-mg-mgr-mg-MA-Scenarioset7-7-3optioneel />
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="4" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="5"|Naamgegevens
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="6"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Initialen
 
|style="background-color: white;"|R.
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Geslachtsnaam
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Achternaam
 
|style="background-color: white;"|XXX-TEST-E
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Identificatienummer
 
|style="background-color: white;"|999990196 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geboortedatum
 
|style="background-color: white;"|5 mei 1970
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
 
|}<section end=patient-mg-mgr-mg-MA-Scenarioset7-7-3optioneel /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset7-7-3optioneel />
 
==== Scenario 7.3 - MBH_920_magistraal90miljoennr-TST====
 
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_magistraal90miljoennr_MA-TST
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="3" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|style="background-color: white;"|MBH_920_magistraal90miljoennr_MA-TST (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Medicatieafspraak datum tijd
 
|style="background-color: white;"|T om 12:08 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="3"|Gebruiksperiode
 
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 30 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|style="background-color: white;"|T
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Einddatum
 
|style="background-color: white;"|T + 30 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Voorschrijver
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgverlener
 
|style="background-color: white;"|Zie [[#d4e375|Zorgverlener: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Farmaceutisch product
 
|style="background-color: white;"|Zie [[#d4e394|Farmaceutisch product: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|style="background-color: white;"|Vanaf T, tot en met T + 30 dagen, 1 maal per dag, cutaan
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|style="background-color: white;"|1 maal per dag
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|style="background-color: white;"|MBH_920_magistraal90miljoennr-TST (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset7-7-3optioneel /><section end=mg-mgr-mg-MA-Scenarioset7-7-3optioneel />
 
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 8 (andermans MA)==
 
<section begin=mg-mgr-mg-MA-Scenarioset8-8-1 /><section begin=patient-mg-mgr-mg-MA-Scenarioset8-8-1 />
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="4" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="5"|Naamgegevens
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="7"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Initialen
 
|style="background-color: white;"|H.
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Geslachtsnaam
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Voorvoegsels
 
|style="background-color: white;"|van
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Achternaam
 
|style="background-color: white;"|XXX_Zutphen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Identificatienummer
 
|style="background-color: white;"|999910498 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geboortedatum
 
|style="background-color: white;"|8 jun 1954
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
 
|}<section end=patient-mg-mgr-mg-MA-Scenarioset8-8-1 /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset8-8-1 />
 
==== Scenario 8.1 - MBH_920_VVandermansMA-ZTP====
 
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_VVandermansMA_MA-ZTP
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="3" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|style="background-color: white;"|MBH_920_VVandermansMA_MA-ZTP (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Medicatieafspraak datum tijd
 
|style="background-color: white;"|T - 14 dagen om 09:00 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="3"|Gebruiksperiode
 
|style="background-color: #E3E3E3;;"|''Vanaf T - 14 dagen, tot en met T + 6 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|style="background-color: white;"|T - 14 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Einddatum
 
|style="background-color: white;"|T + 6 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Voorschrijver
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgverlener
 
|style="background-color: white;"|Zie [[#d4e24|Zorgverlener: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Farmaceutisch product
 
|style="background-color: white;"|Zie [[#d4e43|Farmaceutisch product: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|style="background-color: white;"|Vanaf T - 14 dagen, tot en met T + 6 dagen, 1 maal per dag 1 stuk, oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|style="background-color: white;"|1 maal per dag 1 stuk
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Kopie indicator
 
|style="background-color: white;"|true
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|style="background-color: white;"|MBH_920_VVandermansMA-ZTP (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset8-8-1 /><section end=mg-mgr-mg-MA-Scenarioset8-8-1 />
 
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 8.0 (andermans MA)==
 
<section begin=mg-mgr-mg-MA-Scenarioset8.0-8i-01 /><section begin=patient-mg-mgr-mg-MA-Scenarioset8.0-8i-01 />
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="4" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="5"|Naamgegevens
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="7"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Initialen
 
|style="background-color: white;"|H.
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Geslachtsnaam
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Voorvoegsels
 
|style="background-color: white;"|van
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Achternaam
 
|style="background-color: white;"|XXX_Zutphen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Identificatienummer
 
|style="background-color: white;"|999910498 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geboortedatum
 
|style="background-color: white;"|8 jun 1954
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
 
|}<section end=patient-mg-mgr-mg-MA-Scenarioset8.0-8i-01 /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset8.0-8i-01 />
 
==== Scenario 8i.01 - MBH_920_VVandermansMA-ZTP====
 
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_VVandermansMA_MA-ZTP
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="3" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|style="background-color: white;"|MBH_920_VVandermansMA_MA-ZTP (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Medicatieafspraak datum tijd
 
|style="background-color: white;"|T - 14 dagen om 09:00 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="3"|Gebruiksperiode
 
|style="background-color: #E3E3E3;;"|''Vanaf T - 14 dagen, tot en met T + 6 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|style="background-color: white;"|T - 14 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Einddatum
 
|style="background-color: white;"|T + 6 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Voorschrijver
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgverlener
 
|style="background-color: white;"|Zie [[#d4e24|Zorgverlener: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Farmaceutisch product
 
|style="background-color: white;"|Zie [[#d4e43|Farmaceutisch product: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|style="background-color: white;"|Vanaf T - 14 dagen, tot en met T + 6 dagen, 1 maal per dag 1 stuk, oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|style="background-color: white;"|1 maal per dag 1 stuk
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|style="background-color: white;"|MBH_920_VVandermansMA-ZTP (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset8.0-8i-01 /><section end=mg-mgr-mg-MA-Scenarioset8.0-8i-01 />
 
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 8.0 (andermans MA)==
 
<section begin=mg-mgr-mg-MA-Scenarioset8.0-8i-02 /><section begin=patient-mg-mgr-mg-MA-Scenarioset8.0-8i-02 />
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="4" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="5"|Naamgegevens
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="7"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Initialen
 
|style="background-color: white;"|H.
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Geslachtsnaam
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Voorvoegsels
 
|style="background-color: white;"|van
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Achternaam
 
|style="background-color: white;"|XXX_Zutphen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Identificatienummer
 
|style="background-color: white;"|999910498 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geboortedatum
 
|style="background-color: white;"|8 jun 1954
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
 
|}<section end=patient-mg-mgr-mg-MA-Scenarioset8.0-8i-02 /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset8.0-8i-02 />
 
==== Scenario 8i.02 - MBH_920_stakenandermansMA-ZTP====
 
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_stakenandermansMA_MA1-ZTP
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="3" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|style="background-color: white;"|MBH_920_stakenandermansMA_MA1-ZTP (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Medicatieafspraak datum tijd
 
|style="background-color: white;"|T - 5 dagen om 08:45 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="3"|Gebruiksperiode
 
|style="background-color: #E3E3E3;;"|''Vanaf T - 5 dagen, tot en met T + 15 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|style="background-color: white;"|T - 5 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Einddatum
 
|style="background-color: white;"|T + 15 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Voorschrijver
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgverlener
 
|style="background-color: white;"|Zie [[#d4e248|Zorgverlener: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Farmaceutisch product
 
|style="background-color: white;"|Zie [[#d4e267|Farmaceutisch product: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|style="background-color: white;"|Vanaf T - 5 dagen, tot en met T + 15 dagen, 1 maal per dag 1 stuk, oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|style="background-color: white;"|1 maal per dag 1 stuk
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|style="background-color: white;"|MBH_920_stakenandermansMA-ZTP (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset8.0-8i-02 /><section end=mg-mgr-mg-MA-Scenarioset8.0-8i-02 />
 
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 8.0 (andermans MA)==
 
<section begin=mg-mgr-mg-MA-Scenarioset8.0-8i-03 /><section begin=patient-mg-mgr-mg-MA-Scenarioset8.0-8i-03 />
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="4" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="5"|Naamgegevens
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="7"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Initialen
 
|style="background-color: white;"|H.
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Geslachtsnaam
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Voorvoegsels
 
|style="background-color: white;"|van
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Achternaam
 
|style="background-color: white;"|XXX_Zutphen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Identificatienummer
 
|style="background-color: white;"|999910498 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geboortedatum
 
|style="background-color: white;"|8 jun 1954
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
 
|}<section end=patient-mg-mgr-mg-MA-Scenarioset8.0-8i-03 /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset8.0-8i-03 />
 
==== Scenario 8i.03 - MBH_920_onderbrekenandermansMA-ZTP====
 
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_onderbrekenandermansMA_MA1-ZTP
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="3" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|style="background-color: white;"|MBH_920_onderbrekenandermansMA_MA1-ZTP (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Medicatieafspraak datum tijd
 
|style="background-color: white;"|T - 60 dagen om 09:00 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="3"|Gebruiksperiode
 
|style="background-color: #E3E3E3;;"|''Vanaf T - 60 dagen, tot en met T + 29 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|style="background-color: white;"|T - 60 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Einddatum
 
|style="background-color: white;"|T + 29 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Voorschrijver
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgverlener
 
|style="background-color: white;"|Zie [[#d4e451|Zorgverlener: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Farmaceutisch product
 
|style="background-color: white;"|Zie [[#d4e470|Farmaceutisch product: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|style="background-color: white;"|Vanaf T - 60 dagen, tot en met T + 29 dagen, 1 maal per dag 1 stuk, oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|style="background-color: white;"|1 maal per dag 1 stuk
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|style="background-color: white;"|MBH_920_onderbrekenandermansMA-ZTP (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset8.0-8i-03 /><section end=mg-mgr-mg-MA-Scenarioset8.0-8i-03 />
 
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 8.0 (andermans MA)==
 
<section begin=mg-mgr-mg-MA-Scenarioset8.0-8i-04 /><section begin=patient-mg-mgr-mg-MA-Scenarioset8.0-8i-04 />
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="4" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="5"|Naamgegevens
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="7"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Initialen
 
|style="background-color: white;"|H.
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Geslachtsnaam
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Voorvoegsels
 
|style="background-color: white;"|van
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Achternaam
 
|style="background-color: white;"|XXX_Zutphen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Identificatienummer
 
|style="background-color: white;"|999910498 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geboortedatum
 
|style="background-color: white;"|8 jun 1954
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
 
|}<section end=patient-mg-mgr-mg-MA-Scenarioset8.0-8i-04 /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset8.0-8i-04 />
 
==== Scenario 8i.04 - MBH_920_wijzigenandermansMA-ZTP====
 
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_wijzigenandermansMA_MA1-ZTP
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="3" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|style="background-color: white;"|MBH_920_wijzigenandermansMA_MA1-ZTP (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Medicatieafspraak datum tijd
 
|style="background-color: white;"|T - 7 dagen om 07:50 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="3"|Gebruiksperiode
 
|style="background-color: #E3E3E3;;"|''Vanaf T - 7 dagen, tot en met T + 13 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|style="background-color: white;"|T - 7 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Einddatum
 
|style="background-color: white;"|T + 13 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Voorschrijver
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgverlener
 
|style="background-color: white;"|Zie [[#d4e697|Zorgverlener: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Farmaceutisch product
 
|style="background-color: white;"|Zie [[#d4e716|Farmaceutisch product: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|style="background-color: white;"|Vanaf T - 7 dagen, tot en met T + 13 dagen, 1 maal per dag 2 stuks, Oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|style="background-color: white;"|1 maal per dag 2 stuks
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|style="background-color: white;"|MBH_920_wijzigenandermansMA-ZTP (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset8.0-8i-04 /><section end=mg-mgr-mg-MA-Scenarioset8.0-8i-04 />
 
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 10 (HPKZI)==
 
<section begin=mg-mgr-mg-MA-Scenarioset10-10-1optioneel /><section begin=patient-mg-mgr-mg-MA-Scenarioset10-10-1optioneel />
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="4" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="5"|Naamgegevens
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="7"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Initialen
 
|style="background-color: white;"|B.
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Geslachtsnaam
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Voorvoegsels
 
|style="background-color: white;"|van
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Achternaam
 
|style="background-color: white;"|XXX_Kester
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Identificatienummer
 
|style="background-color: white;"|999911557 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geboortedatum
 
|style="background-color: white;"|2 aug 1954
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
 
|}<section end=patient-mg-mgr-mg-MA-Scenarioset10-10-1optioneel /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset10-10-1optioneel />
 
==== Scenario 10.1 - MBH_920_HPKvoorschrijven-KST====
 
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_HPKvoorschrijven_MA-KST
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="3" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|style="background-color: white;"|MBH_920_HPKvoorschrijven_MA-KST (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Medicatieafspraak datum tijd
 
|style="background-color: white;"|T - 170 dagen om 13:00 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="3"|Gebruiksperiode
 
|style="background-color: #E3E3E3;;"|''Vanaf T - 170 dagen, tot en met T - 21 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|style="background-color: white;"|T - 170 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Einddatum
 
|style="background-color: white;"|T - 21 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Voorschrijver
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgverlener
 
|style="background-color: white;"|Zie [[#d4e24|Zorgverlener: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Farmaceutisch product
 
|style="background-color: white;"|Zie [[#d4e43|Farmaceutisch product: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|style="background-color: white;"|Vanaf T - 170 dagen, tot en met T - 21 dagen, 1 maal per dag 1 stuk, Oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|style="background-color: white;"|1 maal per dag 1 stuk
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|style="background-color: white;"|MBH_920_HPKvoorschrijven-KST (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset10-10-1optioneel /><section end=mg-mgr-mg-MA-Scenarioset10-10-1optioneel />
 
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 10 (HPKZI)==
 
<section begin=mg-mgr-mg-MA-Scenarioset10-10-2optioneel /><section begin=patient-mg-mgr-mg-MA-Scenarioset10-10-2optioneel />
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="4" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="5"|Naamgegevens
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="7"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Initialen
 
|style="background-color: white;"|B.
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Geslachtsnaam
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Voorvoegsels
 
|style="background-color: white;"|van
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Achternaam
 
|style="background-color: white;"|XXX_Kester
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Identificatienummer
 
|style="background-color: white;"|999911557 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geboortedatum
 
|style="background-color: white;"|2 aug 1954
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
 
|}<section end=patient-mg-mgr-mg-MA-Scenarioset10-10-2optioneel /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset10-10-2optioneel />
 
==== Scenario 10.2 - MBH_920_ZINRvoorschrijven-KST====
 
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_ZINRvoorschrijven_MA-KST
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|colspan="3" width="25%"| Gegevenselement
 
|| Waarde
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|style="background-color: white;"|MBH_920_ZINRvoorschrijven_MA-KST (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Medicatieafspraak datum tijd
 
|style="background-color: white;"|T om 13:05 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="3"|Gebruiksperiode
 
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 150 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|style="background-color: white;"|T
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Einddatum
 
|style="background-color: white;"|T + 150 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Voorschrijver
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgverlener
 
|style="background-color: white;"|Zie [[#d4e152|Zorgverlener: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Farmaceutisch product
 
|style="background-color: white;"|Zie [[#d4e171|Farmaceutisch product: ]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
|colspan="4"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|style="background-color: white;"|Vanaf T, tot en met T + 150 dagen, 1 maal per dag 1 stuk, Oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|style="background-color: white;"|1 maal per dag 1 stuk
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|style="background-color: white;"|MBH_920_ZINRvoorschrijven-KST (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset10-10-2optioneel /><section end=mg-mgr-mg-MA-Scenarioset10-10-2optioneel />
 
 
[[Categorie:Kwalificatie]]
 

Huidige versie van 30 sep 2022 om 13:40

Tabel 1. Overzicht situaties specifieke en generieke MBH-id voor EVS en AIS
Situatie EVS AIS ETDR
Migreren van actuele en recent gestopte medicatie Specifieke MBH-id Generieke MBH-id Generieke MBH-id
Migreren van historische medicatie Generieke MBH-id Generieke MBH-id Generieke MBH-id
Starten van nieuwe MBH Specieke MBH-id Generieke MBH-id[1] Generieke MBH-id
  1. AIS initieert in principe géén specifieke MBH-id. Alleen wanneer er geen PRK is, maakt het AIS een specifieke MBH-id aan (zie paragraaf Bijzondere situaties).